prof.dr. (Werner) WBF Brouwer

Dean Erasmus School of Health Policy & Management

Location: Burg. Oudlaan 50, Rotterdam
Telephone: 0104088525
Email: brouwer@eshpm.eur.nl

More information

Profile

Werner Brouwer (1972) is a Professor of Health Economics within the Erasmus School of Health Policy & Management (ESHPM) of the Erasmus University Rotterdam.

He obtained an MSc in Economics (1996) and a PhD in Health Economics (1999) at the same university. Werner is also affiliated with the institute for Medical Technology Assessment and the Erasmus School of Economics. Moreover, he is an Honorary University Professor at the Corvinus University in Budapest, Hungary.

His research focuses on the methodology of welfare economic evaluations in health care. His work has covered topics like optimal decision rules, normative foundations of economic evaluations in health, measurement and valuation of informal care and productivity costs, incorporating equity considerations in economic evaluations as well as the monetary value of health gains. In addition, he has performed work on the link between economic evaluation and health policy, behavioral economics and public health economics. He published extensively on these topics including in journals like Health Economics, Journal of Health Economics, Medical Decision Making, Social Science & Medicine and British Medical Journal.

Werner has been involved in several courses taught in the bachelor phase as well as in the international Master of Health Economics, Policy and Law (HEPL) of the Erasmus School of Health Policy & Management. So far, he has supervised 12 completed PhD theses. From 2012-2018 he was Dean of ESHPM.

Werner is an Associate Editor of Health Economics and a member of the Editorial Boards of the European Journal of Health Economics, PharmacoEconomics and Cost-Effectiveness and Resource Allocation. He is a member of the European Commission Expert Panel on Effective Ways of Investing in Health and the independent chairman of the Foundation for Top Clinical Mental Health Care (TOPGGz) and chairs the Erasmus Initiative Smarter Choices for Better Health of the Erasmus University Rotterdam.

- S.P.I. Huls, A. Sajjad, T.A. Kanters, L. Hakkaart-van Roijen, W.B.F. Brouwer & N.J.A. van Exel (2021). Tijdens lockdown maakten werkenden minder uren en kregen ze minder gedaan. Economisch-Statistische Berichten, 106 (4793), 11-13. [go to publisher's site]
  N. Varghese, I. Sabat, S. Neumann - Bohme, J. Schreyögg, T. Stargardt, A. Torbica, N.J.A. van Exel, P. Pita Barros & W.B.F. Brouwer (2020). Europeans know and act on WHO recommendations during COVID-19. VoxEU.org.
  W.B.F. Brouwer, N.J.A. van Exel & R.J. Hoefman (2014). Zorgen voor geluk. M en O, 124-132.
  W.B.F. Brouwer (2012). Het complexe dossier gepaste zorg. Economisch-Statistische Berichten, 97 (4644s), 6-14.
  W.B.F. Brouwer & N.J.A. van Exel (2012). Een gepaste waarde van gezondheid. Economisch-Statistische Berichten, 97 (4644S), 50-58.
  T.A. Westra, M. Parouty, W.B.F. Brouwer, P. Beutels, R.M. Rogoza, M.H. Rozenbaum, T. Daemen, J.C. Wilschut, C. Boersma & M.J. Postma (2012). Discounting of Health Gains from Human Papillomavirus Vaccination: Effects of Different Approaches. Value in Health, 15 (3), 562-567. doi: 10.1016/j.jval.2012.01.005
  E.J. van de Wetering, N.J.A. van Exel & W.B.F. Brouwer (2011). De puzzel van geluk en gezondheid van pubers. VGE Bulletin, 2, 3-6.
  R.J. Hoefman, N.J.A. van Exel & W.B.F. Brouwer (2010). Het meten en waarderen van mantelzorg met CarerQol. TSG, 88 (4), 172-176.
  R.J. Hoefman, N.J.A. van Exel & W.B.F. Brouwer (2010). Laat zorgverlener bij ouderenzorg samenwerken met vrienden en familie. VGE Bulletin, 10, 16-18.
  F.F.H. Rutten & W.B.F. Brouwer (2010). Behoedzaam bezuinigen in de zorg. Economisch-Statistische Berichten, 95 (4586), 343-344.
  P.H.M. van Baal, W.B.F. Brouwer, G.A. de Wit, R.T. Hoogeveen & J.J. Polder (2008). De invloed van roken en overgewicht op zorguitgaven. TSG, 86 (3), 150-155.
  W.B.F. Brouwer, N.J.A. van Exel & P.H.M. van Baal (2008). Kosten in de gewonnen levensjaren niet langer negeren! TSG, 86 (1), 1-1.
  J. Polder & W.B.F. Brouwer (2008). Tien woorden gezondheidseconomie. 4. Rechtvaardige verdeling: het verhaal van Bart, Werner, Johan en Kees. TSG, 63-68.
  W.B.F. Brouwer & E.A. Stolk (2007). De grenzen van het pakket. IKR-bulletin (Rotterdam), 31, 22-23.
  W.B.F. Brouwer & J.J. Polder (2007). Gereguleerde concurrentie: broodnodig. Tien woorden gezondheidseconomie. TSG, 85 (8), 417-422.
  J. Polder & W.B.F. Brouwer (2007). Een mistroostige wetenschap? TSG, 85 (4), 202-204.
  W.B.F. Brouwer & J. Polder (2007). Nuttige verzekering: Het verhaal van Kees, Truus, Bert & Bertine en Al. TSG, 85 (6), 303-305.
  F.F.H. Rutten & W.B.F. Brouwer (2007). "Value for money" in de zorg; geen woorden maar daden. M en O, 61, 171-179.
  W.B.F. Brouwer (2007). De markt is geen zorg! TSG, 4 (84), 193-194.
  W.B.F. Brouwer, N.J.A. van Exel & P.H.M. van Baal (2007). De kosten in gewonnen levensjaren - tijd voor een nieuwe richtlijn! VGE Bulletin, 24 (1), 11-14.
  N.J.A. van Exel, M. Moree, M.A. Koopmanschap, T. Schreuder Goedheijt & W.B.F. Brouwer (2006). Respijtzorg: Een verkenning van behoefte en gebruik onder 273 mantelzorgers. TSG, 84 (2), 90-99.
  W.B.F. Brouwer, N.J.A. van Exel & F.T. Schut (2006). De markt is geen zorg! TSG, 84 (4), 193-194.
  W.B.F. Brouwer & F. Calkoen (2006). Keuzen in de Zorg Moeilijk maar noodzakelijk. Nederlands Tijdschrift voor Mondhygiene, 18-21.
  W.B.F. Brouwer, N.J.A. van Exel, J. Polder & P.H.M. van Baal (2006). Gezond leven niet per se goedkoper. Medisch Contact, 61 (21), 878-881.
  I.C.S. Maas, W.B.F. Brouwer & N.J.A. van Exel (2006). Zorg in eigen regie, of liever niet? Houdingen onder mensen van 55 jaar enouden ten aanzien van het PGB als alternatief voor zorg in natura. TSG, 84 (7), 394-402.
  G. de Graaf, W.B.F. Brouwer & N.J.A. van Exel (2006). Gezondheidshoudingen van jongeren in klas 1 en 2 van het voortgezet onderwijs. TSG, 4, 215-222.
  W.B.F. Brouwer (2006). Economie is goed voor volksgezondheid en zorg! TSG, 84 (5), 3-3.
  W.B.F. Brouwer, P.H.M. van Baal & N.J.A. van Exel (2006). De dubbele prijs van succes: The pain is in the gain. TSG, 84, 7-10.
  Y.W. van Kemenade & W.B.F. Brouwer (2006). Lang verwacht en toch gekomen: de stelselherziening. ZM Magazine, 2, 6-9.
  W.B.F. Brouwer & F.F.H. Rutten (2005). Optimale zorg dient onafhankelijk te worden vastgesteld, juist nu! TSG, 83 (5), 326-329.
  W.B.F. Brouwer (2005). Ongelijkheid om positief te prikkelen: nuttig en rechtvaardig. TSG, 83, 181-182.
  W.B.F. Brouwer, F.E. van Nooten & F.F.H. Rutten (2004). Nog veel te winnen met betere richtlijnen. TSG, 8, 523-526.
  M.J. Al & W.B.F. Brouwer (2004). Stimuleren doelmatig gebruik van zuurpompremmers in de onderhoudsbehandeling. TSG, 82, 191-195.
  W.B.F. Brouwer & F.F.H. Rutten (2004). Met het oog op gepaste zorg. RVZ, 7, 53-53.
  W.B.F. Brouwer & F.F.H. Rutten (2004). Bittere pillen. Medisch Contact, 59, 1114-1116.
  F.T. Schut & W.B.F. Brouwer (2004). De preferente apotheker? Jazeker! Economisch-Statistische Berichten, 269.
  G.A. de Wit & W.B.F. Brouwer (2004). Economische evaluaties van gvo-programma's. Forum, 120-123.
  W.B.F. Brouwer & F.F.H. Rutten (2003). Besparen in de praktijk. Medisch Contact, 58, 1406-1408.
  W.B.F. Brouwer (2003). Regeren is vooruitzien, niet achterom kijken. TSG, 81, 307-308.
  W.B.F. Brouwer, M.A.J.M. Buijsen & F.F.H. Rutten (2003). Op naar een nationaal instituut voor effectiviteit en doelmatigheid in de zorg. TSG, 81, 293-296.
  N.J.A. van Exel & W.B.F. Brouwer (2003). Jeugdroken: rol voor overheid en ouders. TSG, 81, 24-26.
  N.J.A. van Exel, M.A. Koopmanschap & W.B.F. Brouwer (2003). Kostbaar ontslag, korte verpleegduur brengt mantelzorgers in de problemen. Medisch Contact, 58, 1272-1274.
  W.B.F. Brouwer, E.H. Hulst, F.E. van Nooten & F.F.H. Rutten (2003). Generieke substitutie. TSG, 81, 162-165.
  M.J. Poleij, E.A. Stolk, W.B.F. Brouwer & J.J. van Busschbach (2002). Ziektelast als criterium: Overheid wil geneesmiddelen beperken. Medisch Contact, 57 (46), 1697-1700.
  W.B.F. Brouwer, N.J.A. van Exel & A.P. Stoop (2002). Grensoverschrijdende zorg niet in trek. Economisch-Statistische Berichten, 87, 30-31.
  W.B.F. Brouwer & F.F.H. Rutten (2002). Geef de dokter maar de schuld. Medisch Contact, 57 (14), 540-541.
  W.B.F. Brouwer, A.H.E. Koolman & M.A.J.M. Buijsen (2002). Grenzeloos informeren. Medisch Contact, 57 (39), 737-740.
  W.B.F. Brouwer & F.F.H. Rutten (2002). Een gouden pil voor apothekers. Generiek voorschrijven is nauwelijks kostenbesparend. Medisch Contact, 57 (19), 737-740.
  I.M. van Exel, N.J.A. van Exel & W.B.F. Brouwer (2002). Het notariaat aan banden. Economisch-Statistische Berichten, 87, 151-153.
  N.J.A. van Exel & W.B.F. Brouwer (2001). Lekker belangrijk. Economisch-Statistische Berichten, 16 (2-01), 155-157.
  W.B.F. Brouwer & F.F.H. Rutten (2001). GVS geeft verkeerde signalen. Economisch-Statistische Berichten, 86, 884-888.
  W.B.F. Brouwer & N.J.A. van Exel (2001). Zorgelijk vervoersbeleid. Economisch-Statistische Berichten, 86, 328-329.
  W.B.F. Brouwer & H.E.G.M. Hermans (2001). Europese regelgeving grijpt in op nationaal zorgstelsel. TSG, 79 (3), 176-179.
  W.B.F. Brouwer & F.T. Schut (2001). Ethische dilemma,s in het nieuwe zorgstelsel. Economisch-Statistische Berichten, 7, 1-1.
  W.B.F. Brouwer, H.E.G.M. Hermans & E.K.A. van Doorslaer (2001). Zorg in en om Europa. ZorgVisie (Maarssen), 3, 24-29.
  A.P. Stoop & W.B.F. Brouwer (2001). De patiënt achter de cijfers. Medisch Contact, 56 (44), 1610-1612.
  E.A. Stolk, W.B.F. Brouwer & J.J. van Busschbach (2000). Vergoeding van viagra stuit op waarden en normen. Medisch Contact, 55 (17), 626-629.
  F.T. Schut & W.B.F. Brouwer (2000). Arbeidsdeling. Economisch-Statistische Berichten, 85, 10-13.
  W.B.F. Brouwer (2000). Het verdelen van de schaarste; over het nut van gezondheidseconomisch onderzoek. Medisch Contact, 55 (25), 939-942.
  N.J.A. van Exel, W.B.F. Brouwer & J.J. van Dijk (1999). Speltheorie: Voetbal, vechten en vliegen. Factor D, 10-14.
  W.B.F. Brouwer, J.J. Dijk van & N.J.A. van Exel (1998). Een economische vakantie. Tijdschrift voor Vervoerswetenschap, 3, 317-323.
  W.B.F. Brouwer, J. Dijk van & N.J.A. van Exel (1998). Speltheorie: een inleiding. Tijdschrift voor het Economisch Onderwijs, 195-198.
  W.B.F. Brouwer, J.J. van Dijk & N.J.A. van Exel (1998). De markt voor gebruikte auto's: reputatie- effecten. Tijdschrift voor Vervoerswetenschap, 2, 137-144.
  H.E.G.M. Hermans & W.B.F. Brouwer (1998). Naschrift. Nederlands Juristenblad (NJB), 40, 1823-1824.
  W.B.F. Brouwer, F.T. Schut & F.F.H. Rutten (1997). Naschrift. Economisch-Statistische Berichten, 153-154.
  
  S.F.W. Himmler, V.R. Soekhai, N.J.A. van Exel & W.B.F. Brouwer (2021). What works better for preference elicitation among older people? Cognitive burden of discrete choice experiment and case 2 best-worst scaling in an online setting. Journal of Choice Modelling, 38:100265. doi: 10.1016/j.jocm.2020.100265
  N. Elsem Varghese, I. Sabat, S. Neumann - Boehme, J. Schreyögg, T. Stargardt, A. Torbica, N.J.A. van Exel, P.P. Barros & W.B.F. Brouwer (2021). Risk communication during COVID-19: A descriptive study on familiarity with, adherence to and trust in the WHO preventive measures. PLoS One (online). doi: 10.1371/ journal.pone.0250872
  V.T. Reckers - Droog, N.J.A. van Exel & W.B.F. Brouwer (2021). Willingness to pay for quality and length of life gains in end of life patients of different ages. Social Science & Medicine:113987. doi: 10.1016/j.socscimed.2021.113987
  V.T. Reckers - Droog, N.J.A. van Exel & W.B.F. Brouwer (2021). Willingness to Pay for Health-Related Quality of Life Gains in Relation to Disease Severity and the Age of Patients. Value in Health. doi: 10.1016/j.jval.2021.01.012
  S. Neumann - Boehme, S.A. Lipman, A.E. Attema & W.B.F. Brouwer (2021). Trust me; I know what I am doing investigating the effect of choice list elicitation and domain-relevant training on preference reversals in decision making for others. The European Journal Of Health Economics. doi: 10.1007/s10198-021-01283-3 [go to publisher's site]
  T. Chandler, S. Neumann - Boehme, I. Sabat, P.P. Barros, W.B.F. Brouwer, N.J.A. van Exel, J. Schreyögg, A. Torbica & T. Stargardt (2021). Blood donation in times of crisis: Early insight into the impact of COVID-19 on blood donors and their motivation to donate across European countries. Vox Sanguinis. doi: 10.1111/vox.13103
  S.A. Lipman, W.B.F. Brouwer & A.E. Attema (2020). What is it going to be, TTO or SG? A direct test of the validity of health state valuation. Health Economics, 29 (11), 1475-1481. doi: 10.1002/hec.4131 [go to publisher's site]
  K.M. Kellerborg, W.B.F. Brouwer & P.H.M. van Baal (2020). Costs and benefits of interventions aimed at major infectious disease threats: lessons from the literature. The European Journal Of Health Economics, 21 (9), 1329-1350. doi: 10.1007/s10198-020-01218-4
  C.M. Dieteren, T. Faber, J. van Exel, W.B.F. Brouwer, J.P. Mackenbach & W.J. Nusselder (2020). Mixed evidence for the compression of morbidity hypothesis for smoking elimination - a systematic literature review. European Journal of Public Health, 31 (2), 409-417. doi: 10.1093/eurpub/ckaa235 [go to publisher's site]
  N. Varghese, I. Sabat, S. Neumann - Bohme, J. Schreyögg, T. Stargardt, A. Torbica, N.J.A. van Exel, P. Pita Barros & W.B.F. Brouwer (2020). Risk Communication during COVID-19: Familiarity with, Adherence to and Trust in the WHO Preventive Measures. Covid Economics, 48 (10), 226-241.
  S.F.W. Himmler, N.J.A. van Exel & W.B.F. Brouwer (2020). Estimating the monetary value of health and capability well‑being applying the well‑being valuation approach. The European Journal Of Health Economics, 21, 1235-1244. doi: 10.1007/s10198-020-01231-7
  S.F.W. Himmler, N.J.A. van Exel & W.B.F. Brouwer (2020). Happy with Your Capabilities? Valuing ICECAP-O and ICECAP-A States Based on Experienced Utility Using Subjective Well-Being Data. Medical Decision Making, 40 (4), 498-510. doi: 10.1177/0272989X20923015
  V.T. Reckers - Droog, M. Goorden, Y. dr. Kaminer, L. van Domburgh, W.B.F. Brouwer & L. Hakkaart-van Roijen (2020). Presentation and validation of the Abbreviated Self Completion Teen-Addiction Severity Index (ASC T-ASI): A preference-based measure for use in health-economic evaluations. PLoS One (online), 15 (9), 0-10. doi: 10.1371/journal.pone.0238858 [go to publisher's site]
  S.P.I. Huls, S.M.C. van Osch, W.B.F. Brouwer, N.J.A. van Exel & A. Stiggelbout (2020). Psychometric evaluation of the Health-Risk Attitude Scale (HRAS-13): assessing the reliability, dimensionality and validity in the general population and a patient population. Psychology and Health. doi: 10.1080/08870446.2020.1851689
  C.M. Dieteren, L.D. Samson, M. Schippers, N.J.A. van Exel, W.B.F. Brouwer, M.W.M. Verschuren & S.J. Picavet (2020). The Healthy Aging Index analyzed over 15 years in the general population: The Doetinchem Cohort Study. Preventive Medicine, 139. doi: 10.1016/j.ypmed.2020.106193 [go to publisher's site]
  C.M. Dieteren, W.B.F. Brouwer & J. van Exel (2020). How do combinations of unhealthy behaviors relate to attitudinal factors and subjective health among the adult population in the Netherlands? BMC Public Health, 20:441. doi: 10.1186/s12889-020-8429-y
  J.J. Enzing, S. Vijgen, S. Knies, A. Boer & W.B.F. Brouwer (2020). Do economic evaluations of TAVI deal with learning effects, innovation, and context dependency? A review. Health Policy and Technology. doi: 10.1016/j.hlpt.2020.09.006 [go to publisher's site]
  F.C.W. van Krugten, C.M. van der Feltz-Cornelis, M.A. Boeschoten, S.A.M. Broeckhuysen-Kloth, J.F. van Eck van der Sluijs, E. van Ee, S.M. van Es, M. Schoorl, L.M. Tak, W.B.F. Brouwer & L. Hakkaart-van Roijen (2020). Development and psychometric evaluation of the Transdiagnostic Decision Tool: matched care for patients with a mental disorder in need of highly specialised care. Bjpsych Open, 6 (6). doi: 10.1192/bjo.2020.74 [go to publisher's site]
  M.S. Perry-Duxbury, N.J.A. van Exel, W.B.F. Brouwer, A. Sköldunger, M. Gonçalves‑Pereira, K. Irving, G. Meyer, G. Selbaek, B. Woods, O. Zanetti, F. Verhey, A. Wimo & R.L.H. Handels (2020). A validation study of the ICECAP‑O in informal carers of people with dementia from eight European Countries. Quality of Life Research, 29, 237-251. doi: 10.1007/s11136-019-02317-3 [go to publisher's site]
  S. Neumann - Boehme, N. Varghese, I. Sabat, P.P. Barros, W.B.F. Brouwer, N.J.A. van Exel, J. Schreyögg & T. Stargardt (2020). Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. The European Journal Of Health Economics, 21, 977-982. doi: 10.1007/s10198-020-01208-6 [go to publisher's site]
  K.M. Kellerborg, W.B.F. Brouwer & P.H.M. van Baal (2020). Costs and benefits of early response in the Ebola virus disease outbreak in Sierra Leone. Cost Effectiveness and Resource Allocation. doi: 10.1186/s12962-020-00207-x
  J.J. Enzing, S. Knies, A. Boer & W.B.F. Brouwer (2020). Broadening the application of health technology assessment in the Netherlands: a worthwhile destination but not an easy ride? Health Economics, Policy and Law. doi: 10.1017/S1744133120000237 [go to publisher's site]
  P Baji, M. Farkas, D. Golicki, V. Rupel, R.J. Hoefman, W.B.F. Brouwer, N.J.A. van Exel, Z. Zrubka, L. Gulacsi & M. Pentek (2020). Development of population tariffs for the CarerQol instrument for Hungary, Poland and Slovenia: a discrete choice experiment study to measure the burden of informal caregiving. Pharmacoeconomics (Print), 38 (6), 633-643. doi: 10.1007/s40273-020-00899-2
  S.A. Lipman, W.B.F. Brouwer & A.E. Attema (2020). Living up to expectations: Experimental tests of subjective life expectancy as reference point in time trade-off and standard gamble. Journal of Health Economics, 71:102318. doi: 10.1016/j.jhealeco.2020.102318 [go to publisher's site]
  M. Pentek, N.J.A. van Exel, L. Gulacsi, V. Brodszky, Z. Zrubka, P Baji, F. Rencz & W.B.F. Brouwer (2020). Acceptable health and ageing: comparisons between Hungary and The Netherlands. Health and Quality of Life Outcomes, 18 (1):346. doi: 10.1186/s12955-020-01568-w
  I. Sabat, S. Neumann - Boehme, N. Varghese, P.P. Barros, W.B.F. Brouwer, N.J.A. van Exel, J. Schreyögg & T. Stargardt (2020). United but divided: Policy responses and people’s perceptions in the EU during the COVID-19 outbreak. Health Policy, 124, 909-918. doi: 10.1016/j.healthpol.2020.06.009 [go to publisher's site]
  L.W. ten Hoopen, P.F.A. de Nijs, J. Duvekot, K. Greaves-Lord, M.H.J. Hillegers, W.B.F. Brouwer & L. Hakkaart - van Roijen (2020). Children with an autism spectrum disorder and their caregivers: capturing health-related and care-related quality of life. Journal of Autism and Developmental Disorders, 49 (323), 1-15. doi: 10.1007/s10803-019-04249-w [go to publisher's site]
  V.T. Reckers - Droog, M. Jansen, L. Bijlmakers, R.M.P.M. Baltussen, W.B.F. Brouwer & N.J.A. van Exel (2020). How does participating in a deliberative citizens panel on healthcare priority setting influence the views of participants? Health Policy, 124 (2), 143-151. doi: 10.1016/j.healthpol.2019.11.011 [go to publisher's site]
  V.T. Reckers - Droog, C. Federici, W.B.F. Brouwer & M. Drummond (2020). Challenges with coverage with evidence development schemes for medical devices: A systematic review. Health Policy and Technology, 9 (2), 146-156. doi: 10.1016/j.hlpt.2020.02.006 [go to publisher's site]
  S.F.W. Himmler, N.J.A. van Exel, M.S. Perry-Duxbury & W.B.F. Brouwer (2020). Willingness to pay for an early warning system for infectious diseases. The European Journal Of Health Economics, 21, 763-773. doi: 10.1007/s10198-020-01171-2 [go to publisher's site]
  R. Tarricone, O. Ciani, A. Torbica, W.B.F. Brouwer, G. Chaloutsos, M. Drummond, N. Martelli, U. Persson, R. Leidl, L. Levin, L. Sampietro-Colom & R. Taylor (2020). Lifecycle evidence requirements for high-risk implantable medical devices: a European perspective. Expert Review of Medical Devices, 17 (10), 993-1006. doi: 10.1080/17434440.2020.1825074 [go to publisher's site]
  S.M. Hulst, W.B.F. Brouwer, B. Mol & M.E. van den Akker-van Marle (2020). Challenges in economic evaluations in obstetric care: a scoping review and expert opinion. Bjog-An International Journal of Obstetrics and Gynaecology, 127 (11), 1399-1407. doi: 10.1111/1471-0528.16243
  M.Q.N. Hackert, N.J.A. van Exel & W.B.F. Brouwer (2020). Well-being of Older People (WOOP): Quantitative Validation of a New Outcome Measure for Use in Economic Evaluations. Social Science & Medicine, 259:11310. doi: 10.1016/j.socscimed.2020.113109 [go to publisher's site]
  D.C. Voormolen, N.J.A. van Exel, W.B.F. Brouwer, A. Sköldunger, M. Gonçalves-Pereira, K. Irving, A. Bieber, G. Selbaek, B.M. Woods, O. Zanetti, F. Verhey, A. Wimo & R.L.H. Handels (2020). A validation study of the CarerQol instrument in informal caregivers of people with dementia from eight European countries. Quality of Life Research. doi: 10.1007/s11136-020-02657-5 [go to publisher's site]
  C. Brown, J.M. Tilford, N. Payakachat, K. Williams, K.A. Kuhlthau, J.M. Pyne, R.J. Hoefman & W.B.F. Brouwer (2019). Measuring Caregiver Spillover Effects Associated with Autism Spectrum Disorder: A Comparison of the EQ-5D-3L and SF-6D. Pharmacoeconomics (Print), 37 (4), 609-620. doi: 10.1007/s40273-019-00789-2
  R.J. Hoefman, N.J.A. van Exel & W.B.F. Brouwer (2019). The monetary value of informal care: obtaining pure time valuations using a Discrete Choice Experiment. Pharmacoeconomics (Print), 37 (4), 531-540. doi: 10.1007/s40273-018-0724-4
  M.M. Versteegh, I. Corro Ramos, N.C. Buyukkaramikli, A. Ansaripour, V.T. Reckers - Droog & W.B.F. Brouwer (2019). Severity-Adjusted Probability of Being Cost Effective. Pharmacoeconomics (Print), 37, 1155-1163. doi: 10.1007/s40273-019-00810-8 [go to publisher's site]
  M.S. Perry-Duxbury, N.J.A. van Exel, W.B.F. Brouwer, A. Skoldunger, M. Gonçalves-Pereira, K. Irving, G. Meyer, G. Selbaek, B. Woods, O. Zanetti, F. Verhey, A. Wimo & R.L.H. Handels (2019). How to value safety in economic evaluations in health care? A review of applications in different sectors. The European Journal Of Health Economics, 20 (7), 1041-1061. doi: 10.1007/s10198-019-01076-9 [go to publisher's site]
  S.A. Lipman, W.B.F. Brouwer & A.E. Attema (2019). QALYs without bias? Non-parametric correction of time trade-off and standard gamble weights based on prospect theory. Health Economics, 28 (7), 843-854. doi: 10.1002/hec.3895 [go to publisher's site]
  V.T. Reckers - Droog, N.J.A. van Exel & W.B.F. Brouwer (2019). Equity Weights for Priority Setting in Healthcare: Severity, Age, or Both? Value in Health, 22 (12), 1441-1449. doi: 10.1016/j.jval.2019.07.012 [go to publisher's site]
  M.Q.N. Hackert, W.B.F. Brouwer, R.J. Hoefman & N.J.A. van Exel (2019). Views of older people in the Netherlands on wellbeing: A Q-methodology study. Social Science & Medicine, 240:112535. doi: 10.1016/j.socscimed.2019.112535
  P Baji, D. Golicki, V. Prevolnik-Rupel, W.B.F. Brouwer, Z. Zrubka, L. Gulacsi & M. Pentek (2019). The burden of informal caregiving in Hungary, Poland and Slovenia: results from national representative surveys. The European Journal Of Health Economics, 20 (S1), 5-16. doi: 10.1007/s10198-019-01058-x
  M.Q.N. Hackert, N.J.A. van Exel & W.B.F. Brouwer (2019). Does the ICECAP-O cover the Physical, Mental and Social Functioning of Older People in the UK? Quality of Life Research, 28, 761-770. doi: 10.1007/s11136-018-2042-x
  P.H.M. van Baal, A. Morton, D. Meltzer & W.B.F. Brouwer (2019). Future unrelated medical costs need to be considered in cost effectiveness analysis. The European Journal Of Health Economics, 20, 1-5. doi: 10.1007/s10198-018-0976-0
  S. Knies, J.L. Severens & W.B.F. Brouwer (2019). Integrating clinical and economic evidence in clinical guidelines: More needed than ever! Journal of Evaluation in Clinical Practice, 25 (4), 561-564. doi: 10.1111/jep.12936
  S.A. Lipman, W.B.F. Brouwer & A.E. Attema (2019). A QALY loss is a QALY loss is a QALY loss: a note on independence of loss aversion from health states. The European Journal Of Health Economics, 20 (3), 419-426. doi: 10.1007/s10198-018-1008-9 [go to publisher's site]
  F.C.W. van Krugten, M. Goorden, A.J.L.M. van Balkom, P. van Oppen, D.J.F. van Schaik, W.B.F. Brouwer & L. Hakkaart-van Roijen (2019). The decision tool unipolar depression (DTUD): a new measure to facilitate the early identification of patients with major depressive disorder in need of highly specialized care. BMC Psychiatry, 19:179. doi: 10.1186/s12888-019-2165-9 [go to publisher's site]
  W.B.F. Brouwer & M. Varkevisser (2019). Gezondheidseconomie en mondzorg: een beknopte bloemlezing. Nederlands Tijdschrift voor Tandheelkunde (NTVT), 126, 285-293. doi: 10.5177/ntvt.2019.06.19045
  S.A. Lipman, W.B.F. Brouwer & A.E. Attema (2019). The corrective approach: policy implications of recent developments in QALY measurement based on prospect theory. Value in Health, 22 (7), 816-821. doi: 10.1016/j.jval.2019.01.013 [go to publisher's site]
  V.T. Reckers - Droog, N.J.A. van Exel & W.B.F. Brouwer (2018). Who should receive treatment? An empirical enquiry into the relationship between societal views and preferences concerning healthcare priority setting. PLoS One (online), 13 (6):e0198761. doi: 10.1371/journal.pone.0198761
  L.M. de Vries, P.H.M. van Baal & W.B.F. Brouwer (2018). Future Costs in Cost-Effectiveness Analyses: Past. Present, Future. Pharmacoeconomics (Online). doi: 10.1007/s40273-018-0749-8
  A.E. Attema, W.B.F. Brouwer & J.L. Pinto-Prades (2018). Peer effects in health valuation: The relation between rating of contemporaries' health and own health. Health and Quality of Life Outcomes, 16 (1):148. doi: 10.1186/s12955-018-0978-8
  F.C.W. van Krugten, M. Goorden, A.J.L.M. van Balkom, J. Spijker, W.B.F. Brouwer & L. Hakkaart-van Roijen (2018). Indicators to facilitate the early identification of patients with major depressive disorder in need of highly specialized care: A concept mapping study. Depression and Anxiety, 35 (4), 346-352. doi: 10.1002/da.22741
  A.E. Attema, H.M. Krol, N.J.A. van Exel & W.B.F. Brouwer (2018). New findings from the time trade-off for income approach to elicit willingness to pay for a quality adjusted life year. European Journal of Health Economics (HEPAC), 19 (2), 277-291. doi: 10.1007/s10198-017-0883-9
  A.E. Attema, W.B.F. Brouwer & K. Claxton (2018). Discounting in economic evaluations. Pharmacoeconomics (Print), 36 (7), 745-758. doi: 10.1007/s40273-018-0672-z
  F.E. van Nooten, J.J. van Busschbach, M. Agthoven, N.J.A. van Exel & W.B.F. Brouwer (2018). What should we know about the person behind a TTO? The European Journal Of Health Economics, 19 (9), 1207-1211. doi: 10.1007/s10198-018-0975-1
  W.B.F. Brouwer, P.H.M. van Baal, N.J.A. van Exel & M.M. Versteegh (2018). When is it too expensive? Cost-effectiveness thresholds and health care decision-making. European Journal of Health Economics (HEPAC). doi: 10.1007/s10198-018-1000-4
  R.J. Hoefman, N.J.A. van Exel & W.B.F. Brouwer (2018). The monetary valuation of informal care: obtaining pure time valuations using a Discrete Choice Experiment. Pharmacoeconomics (Print). doi: 10.1007/s40273-018-0724-4
  K. Verbooy, R.J. Hoefman, N.J.A. van Exel & W.B.F. Brouwer (2018). Time is money: Investigating the value of leisure time and unpaid work. Value in Health, 21 (12), 1428-1436. doi: 10.1016/j.jval.2018.04.1828
  P.H.M. van Baal, M.S. Perry-Duxbury, P.L.H. Bakx, M.M. Versteegh, E.K.A. van Doorslaer & W.B.F. Brouwer (2018). A cost-effectiveness threshold based on the marginal returns of cardiovascular hospital spending. Health Economics, 28 (1), 87-100. doi: 10.1002/hec.3831
  V.T. Reckers - Droog, N.J.A. van Exel & W.B.F. Brouwer (2018). Looking back and moving forward: On the application of proportional shortfall in healthcare priority setting in the Netherlands. Health Policy, 122 (6), 621-629. doi: 10.1016/j.healthpol.2018.04.001 [go to publisher's site]
  K. Verbooy, M.N. Wagener, M. Kaddouri, P.D.D.M. Roelofs, H. Miedema, E.C.M. van Gorp, W.B.F. Brouwer & N.J.A. van Exel (2018). Are people living with HIV less productive at work? Aids Care-Psychological and Socio-Medical Aspects of Aids/Hiv, 30 (10), 1265-1272. doi: 10.1080/09540121.2018.1447076
  W.B.F. Brouwer (2018). The inclusion of spill-over effects in economic evaluations: Not an optional extra. Pharmacoeconomics (Print). doi: 10.1007/s40273-018-0730-6
  S.J. Schawo, W.B.F. Brouwer & L. Hakkaart - van Roijen (2017). Clinicians’ Views on Therapeutic Outcomes of Systemic Interventions and on the Ability of the EQ-5D to Capture these Outcomes. Journal of Mental Health Policy and Economics, 20 (3), 131-136.
  E.J. van de Wetering, N.J.A. van Exel & W.B.F. Brouwer (2017). The risk of conditional reimbursement: Stopping reimbursement can be more difficult than not starting in the first place! Value in Health, 20 (1), 118-125. doi: 10.1016/j.jval.2016.09.001
  S. Wouters, N.J.A. van Exel, R. Baker & W.B.F. Brouwer (2017). Priority to end of life treatments? Views of the public in the Netherlands. Value in Health, 20 (1), 107-117. doi: 10.1016/j.jval.2016.09.544
  M. Gheorghe, S. Picavet, M. Verschuren, W.B.F. Brouwer & P.H.M. van Baal (2017). Health losses at the end of life: a Bayesian mixed beta regression approach. Journal of the Royal Statistical Society. Series A. Statistics in Society, 180 (3), 723-749. doi: 10.1111/rssa.12230
  F.E. van Nooten, W.B.F. Brouwer, J. van Exel, K. Houghton, M. van Agthoven & D.A. Stull (2017). A (Latent) Class of Their Own: Response Patterns in Trading Off Quantity and Quality of Life in Time Trade-Off Exercises. Value in Health, 20 (10), 1403-1410. doi: 10.1016/j.jval.2017.06.008
  M.Q.N. Hackert, J. van Exel & W.B.F. Brouwer (2017). Valid Outcome Measures in Care for Older People: Comparing the ASCOT and ICECAP-O. Value in Health, 20 (7), 936-944. doi: 10.1016/j.jval.2017.03.012
  P.H.M. van Baal, A. Morton, D.O. Meltzer & W.B.F. Brouwer (2017). Should cost effectiveness analyses for NICE always consider future unrelated medical costs? BMJ-British medical journal, Nov 10, 359-359. doi: 10.1136/bmj.j5096 [go to publisher's site]
  S.J. Schawo, C.A.M. Bouwmans - Frijters, E. van der Schee, V. Hendriks, W.B.F. Brouwer & L. Hakkaart - van Roijen (2017). The search for relevant outcome measures for cost-utility analysis of systemic family interventions in adolescents with substance use disorder and delinquent behavior: a systematic literature review. Health and Quality of Life Outcomes, 15:179. doi: 10.1186/s12955-017-0722-9
  S. Wouters, N.J.A. van Exel, K.I.M. Rohde, J.J. Vromen & W.B.F. Brouwer (2017). Acceptable health and priority weighting: discussing a reference-level approach using sufficientarian reasoning. Social Science & Medicine, 181 (May), 158-167. doi: 10.1016/j.socscimed.2017.03.051
  R.J. Hoefman, N.J.A. van Exel & W.B.F. Brouwer (2017). Measuring care-related quality of life of caregivers for use in economic evaluations: CarerQol tariffs for Australia, Germany, Sweden, the UK and the US. Pharmacoeconomics (Print), 35 (4), 469-478. doi: 10.1007/s40273-016-0477-x
  D.R. Rappange, N.J.A. van Exel & W.B.F. Brouwer (2017). A short note on measuring subjective life expectancy: Survival probabilities versus point estimates. The European Journal Of Health Economics, 18 (1), 7-12. doi: 10.1007/s10198-015-0754-1
  H. Mason, N.J.A. van Exel, R. Baker, W.B.F. Brouwer & C. Donaldson (2016). From representing views to representativeness of views: Illustrating a new (Q2S) approach in the context of health care priority setting in nine European countries. Social Science & Medicine, 166, 205-213. doi: 10.1016/j.socscimed.2016.08.036
  E.J. van de Wetering, N.J.A. van Exel, J.M. Rose, R.J. Hoefman & W.B.F. Brouwer (2016). Are some QALYs more equal than others? European Journal of Health Economics (HEPAC), 17 (2), 117-127. doi: 10.1007/s10198-014-0657-6
  P.H.M. van Baal, D. Meltzer & W.B.F. Brouwer (2016). Future costs, fixed healthcare budgets and the decision rules of cost-effectiveness analysis. Health Economics, 25 (2), 237-248. doi: 10.1002/hec.3138
  H. Al-Janabi, N.J.A. van Exel, W.B.F. Brouwer, C. Trotter, L. Glennie, L. Hannigan & J. Coast (2016). A framework for including health spillovers in economic evaluation. Medical Decision Making, 36 (2), 176-186. doi: 10.1177/0272989X15605094
  H. Al-Janabi, N.J.A. van Exel, W.B.F. Brouwer, C. Trotter, L. Glennie, L. Hannigan & J. Coast (2016). Measuring health spillovers for economic evaluation: A case study in meningitis. Health Economics, 25 (12), 1529-1544. doi: 10.1002/hec.3259
  H.M. Krol, A.E. Attema, N.J.A. van Exel & W.B.F. Brouwer (2016). Altruistic preferences in TTO: Consideration of effects on others in health state valuations. Medical Decision Making, 36 (2), 187-198. doi: 10.1177/0272989X15615870
  D.R. Rappange, W.B.F. Brouwer & N.J.A. van Exel (2016). A long life in good health: Subjective expectations regarding length and future health-related quality of life. European Journal of Health Economics (HEPAC), 17 (5), 577-589. doi: 10.1007/s10198-015-0701-1
  C.J. Tilling, H.M. Krol, A.E. Attema, A. Tsuchiya, J. Brazier, N.J.A. van Exel & W.B.F. Brouwer (2016). Exploring a new method for deriving the monetary value of a QALY. European Journal of Health Economics (HEPAC), 17 (7), 801-809. doi: 10.1007/s10198-015-0722-9
  P. Wubulihasimu, W.B.F. Brouwer & P.H.M. van Baal (2016). The Impact of Hospital Payment Schemes on Healthcare and Mortality: Evidence from Hospital Payment Reforms in OECD Countries. Health Economics, 25 (8), 1005-1019. doi: 10.1002/hec.3205
  P.P. Barros, W.B.F. Brouwer, S. Thomson & M. Varkevisser (2016). Competition among health care providers: helpful or harmful? European Journal of Health Economics (HEPAC), 17 (3), 229-233. doi: 10.1007/s10198-015-0736-3
  E.J. van de Wetering, N.J.A. van Exel & W.B.F. Brouwer (2016). Health or Happiness? A note on the relative value of health and happiness in rationing decisions. Value in Health, 19 (5), 552-557. doi: 10.1016/j.jval.2016.02.003
  A.E. Attema, W.B.F. Brouwer, O. l'Haridon & J.L. Pinto-Prades (2016). An elicitation of utility for quality of life under prospect theory. Journal of Health Economics, 48, 121-134. doi: 10.1016/j.jhealeco.2016.04.002
  H.M. Krol, J. Papenburg, S.S. Tan, W.B.F. Brouwer & L. Hakkaart-van Roijen (2016). A Noticeable Difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs. European Journal of Health Economics (HEPAC), 17 (4), 391-402. doi: 10.1007/s10198-015-0685-x
  M.M. Versteegh & W.B.F. Brouwer (2016). Patient and general public preferences for health states: A call to reconsider current guidelines. Social Science & Medicine, 165, 66-74. doi: 10.1016/j.socscimed.2016.07.043
  D.R. Rappange, W.B.F. Brouwer & N.J.A. van Exel (2016). Rational expectations? An explorative study of subjective survival probabilities and lifestyle across Europe. Health Expectations, 19 (1), 121-137. doi: 10.1111/hex.12335
  M.M. Versteegh, S. Knies & W.B.F. Brouwer (2016). From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare. Pharmacoeconomics (Print), 34 (11), 1071-1074. doi: 10.1007/s40273-016-0431-y
  A. Morton, A.L. Adler, D. Bell, A. Briggs, W.B.F. Brouwer, K. Claxton, N. Craig, A. Fischer, P. McGregor & P.H.M. van Baal (2016). Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal. Health Economics, 25 (8), 933-938. doi: 10.1002/hec.3366
  F.E. van Nooten, N.J.A. van Exel, D. Eriksson & W.B.F. Brouwer (2016). “Back to the future”: Influence of beliefs regarding the future on TTO answers. Health and Quality of Life Outcomes, 14, 4. doi: 10.1186/s12955-015-0402-6
  E. Vermaire, C. van Loveren, W.B.F. Brouwer & M. Krol (2015). Een economische evaluatie van twee verschillende cariëspreventieve strategieën vergeleken met standaard zorg. Nederlands Tijdschrift voor Tandheelkunde (NTVT), 122, 393-401. doi: 10.5177/ntvt.2015.07/08.15144 [go to publisher's site]
  S. Wouters, N.J.A. van Exel, M. van den Donk, K.I.M. Rohde & W.B.F. Brouwer (2015). Do people desire to be healthier than other people? A short note on positional concerns for health. The European Journal Of Health Economics, 16 (1), 47-54. doi: 10.1007/s10198-013-0550-8
  M. Gheorghe, W.B.F. Brouwer & P.H.M. van Baal (2015). Did the health of the Dutch population improve between 2001 and 2008? Investigating age- and gender-specific trends in quality of life. European Journal of Health Economics (HEPAC), 16 (8), 801-811. doi: 10.1007/s10198-014-0630-4
  M. Gheorghe, W.B.F. Brouwer & P.H.M. van Baal (2015). Quality of life and time to death: have the health gains of preventive interventions been underestimated? Medical Decision Making, 35 (3), 316-327. doi: 10.1177/0272989X14555771
  N.J.A. van Exel, R. Baker, H. Mason, C. Donaldson & W.B.F. Brouwer (2015). Public views on principles for health care priority setting: Findings of a European cross-country study using Q methodology. Social Science & Medicine, 126, 128-137. doi: 10.1016/j.socscimed.2014.12.023
  C.A. de Uyl-de Groot, W.B.F. Brouwer, J.M. de Maeseneer & J. Verweij (2015). Primary care in cancer control: towards mature cancer care. Lancet Oncology, 16 (22), 1226-1227. doi: 10.1016/S1470-2045(15)00294-6 [go to publisher's site]
  E.J. van de Wetering, N.J.A. van Exel, A. Bobinac & W.B.F. Brouwer (2015). Valuing QALYs in Relation to Equity Considerations Using a Discrete Choice Experiment. Pharmacoeconomics (Print), 33, 1289-1300. doi: 10.1007/s40273-015-0311-x
  J.M. Tilford, N. Payakachat, K.A. Kuhlthau, J.M. Pyne, E. Kovacs, J. Bellando, D.K. Williams, W.B.F. Brouwer & R.E. Frye (2015). Treatment for Sleep Problems in Children with Autism and Caregiver Spillover Effects. Journal of Autism and Developmental Disorders, 45 (11), 3613-3623. doi: 10.1007/s10803-015-2507-5
  H.M. Krol & W.B.F. Brouwer (2015). Unpaid work in economic evaluations. Social Science & Medicine, 144, 127-137. doi: 10.1016/j.socscimed.2015.09.008
  F.E. van Nooten, N.J.A. van Exel, A.H.E. Koolman & W.B.F. Brouwer (2015). “Married with children”: The influence of significant others in TTO exercises. Health and Quality of Life Outcomes, 13 (94). doi: 10.1186/s12955-015-0276-7
  A.E. Attema, W.B.F. Brouwer, O. l'Haridon & J.L. Pinto-Prades (2015). Estimating sign-dependent societal preferences for quality of life. Journal of Health Economics, 43, 229-243. doi: 10.1016/j.jhealeco.2015.07.006
  P. Wubulihasimu, W.B.F. Brouwer & P.H.M. van Baal (2015). Does living longer in good health facilitate longer working lives? The relationship between disability and working lives. European Journal of Public Health, 25 (5), 791-795. doi: 10.1093/eurpub/ckv062.
  C.A.M. Boumans, H.M. Krol, J.L. Severens, M.A. Koopmanschap, W.B.F. Brouwer & L. Hakkaart-van Roijen (2015). The iMTA Productivity Cost Questionnaire A Standardized Instrument for Measuring and Valuing Health-Related Productivity Losses. Value in Health, 18, 753-758. doi: 10.1016/j.jval.2015.05.009
  H. Kraijo, N.J.A. van Exel & W.B.F. Brouwer (2015). The perseverance time of informal carers for people with dementia: results of a two-year longitudinal follow-up study. BMC Nursing, 14, 56. doi: 10.1186/s12912-015-0107-5
  S. Wouters, N.J.A. van Exel, K.I.M. Rohde & W.B.F. Brouwer (2015). Are all health gains equally important? An exploration of acceptable health as reference point in health care priority setting. Health and Quality of Life Outcomes, 13, 79. doi: 10.1186/s12955-015-0277-6
  M. Pennington, R. Baker, W.B.F. Brouwer, H. Mason, D. Gyrd Hansen, A. Robinson & C. Donaldson (2015). Comparing WTP values of different types of QALY gain elicited from the general public. Health Economics, 24 (3), 280-293. doi: 10.1002/hec.3018
  M. Péntek, L. Gulácsi, B. Rojkovich, V. Brodszky, N.J.A. van Exel & W.B.F. Brouwer (2014). Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists. The European Journal Of Health Economics, 15 (S1), 83-92. doi: 10.1007/s10198-014-0597-1
  P. Makai, W.B.F. Brouwer, M.A. Koopmanschap, E.A. Stolk & A.P. Nieboer (2014). Quality of life instruments for economic evaluations in health and social care for older people: A systematic review. Social Science & Medicine, 102, 83-93. doi: 10.1016/j.socscimed.2013.11.050
  P. Makai, F. Beckebans, N.J.A. van Exel & W.B.F. Brouwer (2014). Quality of life of nursing home residents with dementia: validation of the German version of the ICECAP-O. PLoS One (print), 9 (3), e92016. doi: 10.1371/journal.pone.0092016
  H. Kraijo, W.B.F. Brouwer, R. de Leeuw, G. Schrijvers & N.J.A. van Exel (2014). The perseverance time of informal carers of dementia patients: validation of a new measure to initiate transition of care at home to nursing home care. Journal of Alzheimers Disease, 40 (3), 631-642. doi: 10.3233/JAD-132420
  N. Payakachat, J.M. Tilford, K.A. Kuhlthau, N.J.A. van Exel, E. Kovacs, J. Bellando, J.M. Pyne & W.B.F. Brouwer (2014). Predicting Health Utilities for Children With Autism Spectrum Disorders. Autism Research, 7 (6), 649-663. doi: 10.1002/aur.1409
  M. Péntek, V. Brodszky, A. Gulácsi, O. Hajdú, N.J.A. van Exel, W.B.F. Brouwer & L. Gulácsi (2014). Subjective expectations regarding length and health-related quality of life in Hungary: results from an empirical investigation. Health Expectations, 17 (5), 696-709. doi: 10.1111/j.1369-7625.2012.00797.x
  A.E. Attema, W.B.F. Brouwer & N.J.A. van Exel (2014). Your right arm for a publication in AER? Economic Inquiry, 52 (1), 495-502. doi: 10.1111/ecin.12013
  A. Bobinac, J. van Exel, F.F.H. Rutten & W.B.F. Brouwer (2014). The value of a QALY: Individual willingness to pay for health gains under risk. Pharmacoeconomics (Print), 32, 75-86. doi: 10.1007/s40273-013-0110-1
  R.J. Hoefman, N.J.A. van Exel, J.M. Rose, E.J. van de Wetering & W.B.F. Brouwer (2014). A discrete choice experiment to obtain a tariff for valuing informal care situations measured with the CarerQol instrument. Medical Decision Making, 34 (1), 84-96. doi: 10.1177/0272989X13492013
  F.E. van Nooten, X. Koolman, J.J.V. van Busschbach & W.B.F. Brouwer (2014). Thirty down, only ten to go?! Awareness and influence of a 10-year time frame in TTO. Quality of Life Research, 23 (2), 377-384. doi: 10.1007/s11136-013-0495-5
  A.E. Attema & W.B.F. Brouwer (2014). Deriving time discounting correction factors for TTO tariffs. Health Economics, 23 (4), 410-425. doi: 10.1002/hec.2921
  H.M. Krol, E.A. Stolk & W.B.F. Brouwer (2014). Predicting productivity based on EQ-5D: an explorative study. The European Journal Of Health Economics, 15 (5), 465-475. doi: 10.1007/s10198-013-0487-y
  E. Vermaire, H.M. Krol, W.B.F. Brouwer & C. van Loveren (2014). Value for money: economic evaluation of two different caries prevention programmes compared with standard care in a randomized controlled trial. Caries Research, 48 (3), 244-253. doi: 10.1159/000356859
  L.M. Niëns & W.B.F. Brouwer (2013). Measuring the affordability of medicines: Importance and challenges. Health Policy, 112, 45-52. doi: 10.1016/j.healthpol.2013.05.018 [go to publisher's site]
  R.J. Hoefman, J. van Exel & W.B.F. Brouwer (2013). Measuring the impact of caregiving on informal carers: a construct validation study of the CarerQol instrument. Health and Quality of Life Outcomes, 11, 1-13. doi: 10.1186/1477-7525-11-173
  A.E. Attema, W.B.F. Brouwer & O. l'Haridon (2013). Prospect theory in the health domain: A quantitative assessment. Journal of Health Economics, 32, 1057-1065. doi: 10.1016/j.jhealeco.2013.08.006
  E.J. van de Wetering, E.A. Stolk, N.J.A. van Exel & W.B.F. Brouwer (2013). Balancing equity and efficiency in the Dutch basis benefits package using the principle of proportional shortfall. The European Journal Of Health Economics, 14, 107-115. doi: 10.1007/s10198-011-0346-7
  C.A.G. Wolfs, A. Kessels, J.L. Severens, W.B.F. Brouwer, M. de Vugt, F.R.J. Verhey & C.D. Dirksen (2013). Predictive Factors for the Objective Burden of Informal Care in People With Dementia: a systematic review. Alzheimer Disease & Associated Disorders, 26 (3), 197-204. doi: 10.1097/WAD.0b013e31823a6108
  A.E. Attema, M.M. Versteegh, M. Oppe, W.B.F. Brouwer & E.A. Stolk (2013). LEAD TIME TTO: LEADING TO BETTER HEALTH STATE VALUATIONS. Health Economics, 22 (4), 376-392. doi: 10.1002/hec.2804
  T.A. Kanters, W.B.F. Brouwer, R.C.J.A. van Vliet, P.H.M. van Baal & J. Polder (2013). A new prevention paradox: The trade-off between reducing incentives for risk selection and increasing the incentives for prevention for health insurers. Social Science & Medicine, 76, 150-158. doi: 10.1016/j.socscimed.2012.10.019
  A.E. Attema & W.B.F. Brouwer (2013). In search of a preferred preference elicitation method: A test of the internal consistency of choice and matching tasks. Journal of Economic Psychology, 39, 126-140. doi: 10.1016/j.joep.2013.07.009
  T.A. Kanters, A.T. van der Ploeg, W.B.F. Brouwer & L. Hakkaart-van Roijen (2013). The impact of informal care for patients with Pompe disease: An application of the CarerQol instrument. Molecular Genetics and Metabolism, 110 (3), 281-286. doi: 10.1016/j.ymgme.2013.07.020
  H.M. Krol, W.B.F. Brouwer & F.F.H. Rutten (2013). Productivity costs in economic evaluations: past, present, future. Pharmacoeconomics (Print), 31 (7), 537-549. doi: 10.1007/s40273-013-0056-3
  A. Bobinac, J. van Exel, F.F.H. Rutten & W.B.F. Brouwer (2013). Valuing QALY gains by applying a societal perspective. Health Economics, 22, 1272-1281. doi: 10.1002/hec.2879
  R.J. Hoefman, J. van Exel & W.B.F. Brouwer (2013). How to include informal care in economic evaluations. Pharmacoeconomics (Print), 31 (12), 1105-1119. doi: 10.1007/s40273-013-0104-z
  P. Makai, M.A. Koopmanschap, W.B.F. Brouwer & A.P. Nieboer (2013). A validation of the ICECAP-O in a population of post-hospitalized older people in the Netherlands. Health and Quality of Life Outcomes, 11 (57). doi: 10.1186/1477-7525-11-57
  P.H.M. van Baal, D. Meltzer & W.B.F. Brouwer (2013). Pharmacoeconomics Guidelines Should Prescribe Inclusion of Indirect Medical Costs! A Response to Grima et al. Pharmacoeconomics (Print), 31, 369-373. doi: 10.1007/s40273-013-0042-9
  S.J. Schawo, H. van Eeren, D.I. Soeteman, M.C. van der Veldt, M.J. Noom, W.B.F. Brouwer, J.J. van Busschbach & L. Hakkaart-van Roijen (2012). Framework for Modelling the Cost-effectiveness of Systemic Interventions Aimed to Reduce Youth Delinquency. The Journal of Mental Health Policy and Economics, 15, 187-196.
  P. Makai, W.B.F. Brouwer, M.A. Koopmanschap & A.P. Nieboer (2012). Capabilities and quality of life in Dutch psycho-geriatric nursing homes: an exploratory study using a proxy version of the ICECAP-O. Quality of Life Research, 21, 801-812. doi: 10.1007/s11136-011-9997-1
  H.M. Krol, W.B.F. Brouwer, J.L. Severens, J. Kaper & S.M.A.A. Evers (2012). Productivity cost calculations in health economic evaluations: Correcting for compensation mechanisms and multiplier effects. Social Science & Medicine, 75, 1981-1988. doi: 10.1016/j.socscimed.2012.07.012
  J.H. Vermaire, N.J.A. van Exel, C. van Loveren & W.B.F. Brouwer (2012). Putting your money where your mouth is: Parents' valuation of good oral health of their children. Social Science & Medicine, 75, 2200-2206. doi: 10.1016/j.socscimed.2012.08.018
  A. Bobinac, N.J.A. van Exel, F.F.H. Rutten & W.B.F. Brouwer (2012). Inquiry into the Relationship between Equity Weights and the Value of the QALY. Value in Health, 15, 1119-1126. doi: 10.1016/j.jval.2012.07.002
  H. Kraijo, W.B.F. Brouwer, R. de Leeuw, G. Schrijvers & N.J.A. van Exel (2012). Coping with caring: Profiles of caregiving by informal carers living with a loved one who has dementia. Dementia, 11 (1), 113-130. doi: 10.1177/1471301211421261
  M.J. Poleij, W.B.F. Brouwer, N.J.A. van Exel & D. Tibboel (2012). Assessing health-related quality-of-life changes in informal caregivers: an evaluation in parents of children with major congenital anomalies. Quality of Life Research, 21 (5), 849-861. doi: 10.1007/s11136-011-9991-7
  J.M. Tilford, N. Payakachat, E.M. Kovacs, J.M. Pyne, W.B.F. Brouwer, T.G. Nick, J. Bellando & K.A. Kuhlthau (2012). Preference-Based Health-Related Quality-of-Life Outcomes in Children with Autism Spectrum Disorders: A Comparison of Generic Instruments. Pharmacoeconomics (Print), 30 (8), 661-679. doi: 10.2165/11597200 [go to publisher's site]
  D.R. Rappange & W.B.F. Brouwer (2012). The evaluation of lifestyle interventions in the Netherlands. Health Economics, Policy and Law, 7 (2), 243-261. doi: 10.1017/S1744133112000023 [go to publisher's site]
  R.F. Pangalila, G.A.M. van den Bos, H.J. Stam, N.J.A. van Exel, W.B.F. Brouwer & M.E. Roebroeck (2012). Subjective caregiver burden of parents of adults with Duchenne. Disability and Rehabilitation, 34 (12), 988-996. doi: 10.3109/09638288.2011.628738
  A. Bobinac, N.J.A. van Exel, F.F.H. Rutten & W.B.F. Brouwer (2012). GET MORE, PAY MORE? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation. Journal of Health Economics, 31, 158-168. doi: 10.1016/j.jhealeco.2011.09.004
  A.E. Attema & W.B.F. Brouwer (2012). The way that you do it? An elaborate test of procedural invariance of TTO, using a choice-based design. The European Journal Of Health Economics, 13, 491-500. doi: 10.1007/s10198-011-0318-y
  L.M. Niëns, E. van de Poel, A. Cameron, M. Ewen, R. Laing & W.B.F. Brouwer (2012). Practical measurement of affordability: an application to medicines. Bulletin of the World Health Organization, 90, 219-227. doi: 10.2471/BLT.10.084087
  A.E. Attema & W.B.F. Brouwer (2012). A test of indepence of discounting from quality of life. Journal of Health Economics, 31, 22-34. doi: 10.1016/j.jhealeco.2011.12.001
  A.E. Attema & W.B.F. Brouwer (2012). Constantly Proving The Opposite? A test of CPTO using a broad time horizon and correcting for discounting. Quality of Life Research, 21 (1), 25-34. doi: 10.1007/s11136-011-9917-4
  C.J. Tilling, H.M. Krol, A. Tsuchiya, J. Brazier, N.J.A. van Exel & W.B.F. Brouwer (2012). Does the EQ-5D Reflect Lost Earnings? Pharmacoeconomics (Print), 1 (30), 47-61. doi: 10.2165/11539910-000000000-00000
  P.H.M. van Baal & W.B.F. Brouwer (2011). PAID 1.0 in Practice A Brief Clarification Regarding its Possibilities and Limitations. Pharmacoeconomics (Print), 29 (6), 545-547. doi: 10.2165/11585600-000000000-00000
  R.J. Hoefman, N.J.A. van Exel, S. Looren-de Jong, W.K. Redekop & W.B.F. Brouwer (2011). A new test of the construct validity of the CarerQol instrument: measuring the impact of informal care giving. Quality of Life Research, 20, 875-887. doi: 10.1007/s11136-010-9829-8
  P.H.M. van Baal, T.L. Feenstra, J.J. Polder, R.T. Hoogenveen & W.B.F. Brouwer (2011). Economic Evaluation and the postponement of health care costs. Health Economics, 20, 432-445. doi: 10.1002/hec.1599
  J.F. O'Mahony, I.M.C.M. de Kok, J.M. van Rosmalen, J.D.F. Habbema, W.B.F. Brouwer & M. van Ballegooijen (2011). Practical implications of differential discounting in cost-effectiveness analyses with varying numbers of cohorts. Value in Health, 14 (4), 438-442. doi: 10.1016/j.jval.2010.09.009
  R.J. Hoefman, N.J.A. van Exel, M.M.E. Foets & W.B.F. Brouwer (2011). Sustained informal care: the feasibility, construct validity and test-retest reliability of the CarerQol-instrument to measure the impact of informal care in long-term care. Aging & Mental Health, 15 (8), 1-10. doi: 10.1080/13607863.2011.575351
  A. Bobinac, N.J.A. van Exel, F.F.H. Rutten & W.B.F. Brouwer (2011). Health Effects in Significant Others: Separating Family and Care-Giving Effects. Medical Decision Making, 4, 292-298. doi: 10.1177/0272989X10374212
  A. Bobinac, W.B.F. Brouwer & N.J.A. van Exel (2011). Discounting future health gains: an empirical enquiry into the influence of growing life expectancy. Health Economics, 20, 111-119. doi: 10.1002/hec.1578
  N. Payakachat, J.M. Tifford, W.B.F. Brouwer, N.J.A. van Exel & S.D. Grosse (2011). Measuring health and well-being effects in family caregivers of children with craniofacial malformations. Quality of Life Research, 20, 1487-1495. doi: 10.1007/s11136-011-9870-2
  H.M. Krol, J. Papenburg, M.A. Koopmanschap & W.B.F. Brouwer (2011). Do Productivity Costs Matter? Pharmacoeconomics (Print), 7, 601-619.
  P.H.M. van Baal, A. Wong, L.C.J. Slobbe, J.J. Polder, W.B.F. Brouwer & G.A. de Wit (2011). Standardizing the Inclusion of Indirect Medical Costs in Economic Evaluations. Pharmacoeconomics (Print), 29 (3), 175-187. doi: 10.2165/11586130-000000000-00000
  C.A.M. de Meijer, W.B.F. Brouwer, M.A. Koopmanschap, B. van den Berg & N.J.A. van Exel (2010). The value of informal care-A further investigation of the feasibility of contingent valuation in informal caregivers. Health Economics, 19, 755-771. doi: 10.1002/hec.1513
  L.M. Niëns, A. Cameron, E. van de Poel, M. Ewen, W.B.F. Brouwer & R. Laing (2010). Quantifying the Impoverishing Effects of Purchasing Medicines: A Cross-Country Comparison of the Affordability of Medicines in the Developing World. PLoS Medicine (print), 7 (8), 1-8. doi: 10.1371/journal.pmed.1000333
  A.E. Attema & W.B.F. Brouwer (2010). The Value of Correcting Values: Influence and Importance of Correcting TTO Scores for Time Preference. Value in Health, 13 (8), 879-884. doi: 10.1111/j.1524-4733.2010.00773.x
  E.J. van de Wetering, N.J.A. van Exel & W.B.F. Brouwer (2010). Piecing the jigsaw puzzle of adolescent happiness. Journal of Economic Psychology, 31, 923-935. doi: 10.1016/j.joep.2010.08.004
  L. Hakkaart-van Roijen, S.S. Tan, L.M.A. Goossens, S.J. Schawo, W.B.F. Brouwer, M.P.M.H. Rutten - van Molken & F.F.H. Rutten (2010). Doelmatigheid in praktijkrichtlijnen voor medicijnen: resultaten van een 'quick scan'. TSG, 4 (88), 175-181.
  W.B.F. Brouwer & F.F.H. Rutten (2010). The efficiency frontier approach to economic evaluation: will it help German policy making? Health Economics, 19, 1128-1131. doi: 10.1002/hec.1644
  W.J. Meerding, G.J. Bonsel, W.B.F. Brouwer, M.C. Stuifbergen & M.L. Essink-Bot (2010). Social Time Preferences for Health and Money Elicited with a Choice Experiment. Value in Health, 13 (4), 368-374. doi: 10.1111/j.1524-4733.2009.00681.x
  D.R. Rappange, W.B.F. Brouwer, F.F.H. Rutten & P.H.M. van Baal (2010). Lifestyle intervention: from cost savings to value for money. Journal of Public Health, 32 (3), 440-447. doi: 10.1093/pubmed/fdp079
  A. Bobinac, N.J.A. van Exel, F.F.H. Rutten & W.B.F. Brouwer (2010). Caring for and caring about: Disentangling the caregiver effect and the family effect. Journal of Health Economics, 29, 549-556. doi: 10.1016/j.jhealeco.2010.05.003
  H. Al-Janabi, E. Frew, W.B.F. Brouwer, D.R. Rappange & N.J.A. van Exel (2010). The inclusion of positive aspects of caring in the Caregiver Strain Index: Tests of feasibility and validity. International Journal of Nursing Studies, 47, 984-993. doi: 10.1016/j.ijnurstu.2009.12.015
  A.E. Attema & W.B.F. Brouwer (2010). On the (not so) constant proportional trade-off in TTO. Quality of Life Research, 19, 489-497. doi: 10.1007/s11136-010-9605-9
  A. Bobinac, N.J.A. van Exel, F.F.H. Rutten & W.B.F. Brouwer (2010). Willingness to Pay for a Quality-Adjusted Life-Year: The Individual Perspective. Value in Health, 13 (8), 1049-1055. doi: 10.1111/j.1524-4733.2010.00781.x
  C.J. Tilling, H.M. Krol, A. Tsuchiya, J. Brazier & W.B.F. Brouwer (2010). In or Out? Income Losses in Health State Valuations: A Review. Value in Health, 13 (2), 298-305. doi: 10.1111/j.1524-4733.2009.00614.x
  A.E. Attema & W.B.F. Brouwer (2009). The correction of TTO-scores for utility curvature using a risk-free utility elicitation method. Journal of Health Economics, 28, 234-243. doi: 10.1016/j.jhealeco.2008.10.004
  W.B.F. Brouwer, S. Grootenboer & P. Sendi (2009). The Incorporation of Income and Leisure in Health State Valuations When the Measure Is Silent: An Empirical Inquiry into the Sound of Silence. Medical Decision Making, 29, 503-512. doi: 10.1177/0272989X09336161
  H.M. Krol, P. Sendi & W.B.F. Brouwer (2009). Breaking the Silence: Exploring the Potential Effects of Explicit Instructions on Incorporating Income and Leisure in TTO Exercices. Value in Health, 12 (1), 172-180. doi: 10.1111/j.1524-4733.2008.00406.x
  F.E. van Nooten, A.H.E. Koolman & W.B.F. Brouwer (2009). The influence of subjective life expectancy on health state valuations using a 10 year TTO. Health Economics, 18, 549-558. doi: 10.1002/hec.1385
  L.M. Niëns & W.B.F. Brouwer (2009). Better measures of affordability required. Lancet (UK), 373, 1081-1081. doi: 10.1016/S0140-6736(09)60649-8
  D.R. Rappange, W.B.F. Brouwer & N.J.A. van Exel (2009). Back to the Consideration of Future Consequences Scale: Time to Reconsider? The Journal of Social Psychology, 149 (5), 562-584. doi: 10.1080/00224540903232324
  J. Holland, N.J.A. van Exel, F.T. Schut & W.B.F. Brouwer (2009). Some pain, no gain: experiences with the no-claim rebate in the Dutch health care system. Health Economics, Policy and Law, 4, 405-424. doi: 10.1017/S1744133109004861
  D.R. Rappange, P.H.M. van Baal, N.J.A. van Exel, T.L. Feenstra, F.F.H. Rutten & W.B.F. Brouwer (2009). I costi sanitari indiretti (non correlati) durante gli anni di vita guadagnati: : Devono essere inclusi nelle valutazioni economiche degli interventi sanitari? Pharmacoeconomics Italian Research Articles, 11 (1), 55-70.
  A.C.G. van Hooren, W.B.F. Brouwer, R. de Bree, O.S. Hoekstra, C.R. Leemans & C.A. de Uyl-de Groot (2009). The cost-effectiveness of FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy. European Archives of Oto-Rhino-Laryngology, 266 (9), 1441-1448.
  M.J. Poleij, E.A. Stolk & W.B.F. Brouwer (2009). The use and impact of HTA in decision making in the Netherlands. Euro Observer, 11 (1), 7-8.
  D.R. Rappange, W.B.F. Brouwer, R.T. Hoogenveen & P.H.M. van Baal (2009). Healthcare Costs and Obesity Prevention Drug Costs and Other Sector-Specific Consequences. Pharmacoeconomics (Print), 27 (12), 1031-1044. doi: 10.2165/11319900-000000000-00000
  M.A. Koopmanschap, N.J.A. van Exel, B. van den Berg & W.B.F. Brouwer (2008). An overview of methods and applications to value informal care in economic evaluations of healthcare. Pharmacoeconomics (Print), 26 (4), 269-280. doi: 10.2165/00019053-200826040-00001
  P.H.M. van Baal, J.J. Polder, G.A. de Wit, R.T. Hoogeveen, T.L. Feenstra, H.C. Boshuizen, P. Engelfriet & W.B.F. Brouwer (2008). Lifetime medical costs of obesity: pevention no cure for increasing health expenditure. PLoS Medicine (print), 5 (2), 242-249. doi: 10.1371/journal.pmed.0050029
  M.J. Poleij, W.B.F. Brouwer, J.J.V. van Busschbach, F.W.J. Hazebroek, D. Tibboel, F.F.H. Rutten & J.C. Molenaar (2008). Cost-effectiveness of neonatal surgery: first greeted with scepticism, now increasingly accepted. Pediatric Surgery International, 24 (2), 119-127. doi: 10.1007/s00383-007-2045-0
  N.J.A. van Exel, M. de Ruiter & W.B.F. Brouwer (2008). When time is not on your side. Patient experiences with waiting for home care and admission to a nursing or residential home. Patient 2008, 1 (1), 55-71.
  B. van den Berg, M.J. Al, N.J.A. van Exel, M.A. Koopmanschap & W.B.F. Brouwer (2008). Economic valuation of informal care: conjoint analysis applied in a heterogeneous population of informal caregivers. Value in Health, 11 (7), 1041-1050. doi: 10.1111/j.1524-4733.2008.00357.x
  W.B.F. Brouwer, N.J.A. van Exel, R. Baker & C. Donaldson (2008). The New Myth The Social Value of QUALY. Pharmacoeconomics (Print), 26 (1), 1-4.
  T.L. Feenstra, P.H.M. van Baal, A. Gandjour & W.B.F. Brouwer (2008). Future medical costs in economic evaluations. A comment on Lee. Journal of Health Economics, 27 (6), 1645-1649. doi: 10.1016/j.jhealeco.2008.07.007
  N.J.A. van Exel, A. Bobinac, M.A. Koopmanschap & W.B.F. Brouwer (2008). The invisible hands made visible: Recognizing the value of informal care in health care decision making. Expert review of pharmacoeconomics & outcomes research, 8 (6), 557-561. doi: 10.1586/14737167.8.6.557
  W.B.F. Brouwer (2008). Perspective, costs, outcomes and discouting in economic evaluations. European Journal of Hospital Pharmacy Practice, 14 (3), 20-22.
  A.E. Attema & W.B.F. Brouwer (2008). Can we fix it? Yes we can! But what? A new test of procedural invariance in TTO-measurement. Health Economics, 17, 877-885. doi: 10.1002/hec.1315
  W.B.F. Brouwer, A.J. Culyer, N.J.A. van Exel & F.F.H. Rutten (2008). Welfarism vs. extra-welfarism. Journal of Health Economics, 27, 325-338. doi: 10.1016/j.jhealeco.2007.07.003
  N.J.A. van Exel, G. de Graaf & W.B.F. Brouwer (2008). Give me a break! Informal caregiver attitudes towards respite care. Health Policy, 88, 73-87. doi: 10.1016/j.healthpol.2008.03.001
  D.R. Rappange, P.H.M. van Baal, F.F.H. Rutten, N.J.A. van Exel, T.L. Feenstra & W.B.F. Brouwer (2008). Unrelated medical costs in life-years gained should they be included in economic evaluations of healthcare interventions? Pharmacoeconomics (Print), 26 (10), 815-860. doi: 10.2165/00019053-200826100-00003
  N.J.A. van Exel, G. de Graaf & W.B.F. Brouwer (2007). Care for a break? An investigation of informal caregivers' attitudes toward respite care using Q-methodology. Health Policy, 83, 332-342. doi: 10.1016/j.healthpol.2007.02.002
  H. Gravelle, W.B.F. Brouwer, L.W. Niessen, M. Postma & F.F.H. Rutten (2007). Discouting in economic evaluations: stepping forward towards optima decision rules. Health Economics, 16, 307-317. doi: 10.1002/hec.1168
  P.H.M. van Baal, W.B.F. Brouwer, R.T. Hoogeveen & T.L. Feenstra (2007). Increasing tobacco taxes: A cheap tool to increase public health. Health Policy, 82, 142-152. doi: 10.1016/j.healthpol.2006.09.004
  P.H.M. van Baal, T.L. Feenstra, R.T. Hoogenveen, G.A. de Wit & W.B.F. Brouwer (2007). Unrealated medical care in life years gained and the cost utility of primary prevention: in search of a 'perfect' cost-utility ratio. Health Economics, 16, 421-433. doi: 10.1002/hec.1181
  P. Sendi, W.B.F. Brouwer, H. Bucher, R. Weber & M. Battegay (2007). When time is more than money; The allocation of time between work and leisure in HIV-infected patients. Social Science & Medicine, 64, 2355-2361. doi: 10.1016/j.socscimed.2007.02.032
  N.J.A. van Exel, A. Bobinac, M.A. Koopmanschap & W.B.F. Brouwer (2007). Providing informal care: a burden and a blessing. Health and Ageing, 16, 10-13.
  W.B.F. Brouwer, N.J.A. van Exel, P.H.M. van Baal & J. Polder (2007). Economics and public health: Engaged to be happily married! European Journal of Public Health, 17 (2), 122-123. doi: 10.1093/eurpub/ckl074
  W.B.F. Brouwer, N.J.A. van Exel, R.M.P.M. Baltussen & F.F.H. Rutten (2006). A Dollar is a Dollar Is a Dollar - or Is It? Value in Health, 9 (5), 341-347. doi: 10.1111/j.1524-4733.2006.00123.x
  B. van den Berg, W.B.F. Brouwer, N.J.A. van Exel, M.A. Koopmanschap, G. van den Bos & F.F.H. Rutten (2006). Economic valuation of informal care: Lessons from the application of the oppurtunity costs and proxy good methods. Social Science & Medicine, 62, 835-845. doi: 10.1016/j.socscimed.2005.06.046
  W.B.F. Brouwer (2006). Too Important to Ignore. Pharmacoeconomics (Print), 24, 39-41.
  N.J.A. van Exel, W.B.F. Brouwer, B. van den Berg & M.A. Koopmanschap (2006). With a little help from an anchor; Discussion and evidence of anchoring effects in contigent valuation. Journal of Socio-economics, 35, 836-853.
  H.M. Krol, W.B.F. Brouwer & P. Sendi (2006). Productivity Costs in Health -State Valuations. Pharmacoeconomics (Print), 24, 401-414.
  N.J.A. van Exel, M. Moree, M.A. Koopmanschap, T. Scheuder Goedheijt & W.B.F. Brouwer (2006). Respite care- An explorative study of demand and use in Dutch informal caregivers. Health Policy, 78, 194-198. doi: 10.1016/j.healthpol.2005.11.002
  W.B.F. Brouwer, N.J.A. van Exel, B. van Gorp & W.K. Redekop (2006). The CarerQol instrument: A new instrument to measure care-related quality of life of informal caregivers for use in economic evaluations. Quality of Life Research, 15, 1005-1021. doi: 10.1007/s11136-005-5994-6
  P. Sendi & W.B.F. Brouwer (2005). Is silence golden? A test of the incorporation of the effects of ill-health on income and leisure in health state valuations. Health Economics, 14 (6), 643-647. doi: 10.1002/hec.971
  W.B.F. Brouwer, W.J. Meerding, L.M. Lamers & J.L. Severens (2005). The relationship between productivity and health-related QOL: an exploration. Pharmacoeconomics (Print), 23 (3), 209-218. doi: 10.2165/00019053-200523030-00002
  W.B.F. Brouwer, N.J.A. van Exel, B. van der Berg, G. van den Bos & M.A. Koopmanschap (2005). Process utility from providing informal care: the benefit of caring. Health Policy, 74 (1), 85-99. doi: 10.1016/j.healthpol.2004.12.008
  W.B.F. Brouwer & N.J.A. van Exel (2005). Expectations regarding length and health related quality of life: Some empirical findings. Social Science & Medicine, 61 (5), 1083-1094. doi: 10.1016/j.socscimed.2005.01.008
  M.A. Koopmanschap, W.B.F. Brouwer, L. van Roijen & N.J.A. van Exel (2005). Influence of waiting time on cost-effectiveness. Social Science & Medicine, 60 (11), 2501-2504. doi: 10.1016/j.socscimed.2004.11.022
  N.J.A. van Exel, M.A. Koopmanschap, B. van der Berg, W.B.F. Brouwer & G. van den Bos (2005). Burden of informal caregiving for stroke patients - Identification of caregivers at risk of adverse health effects. Cerebrovascular Diseases, 19 (1), 11-17. doi: 10.1159/000081906
  W.B.F. Brouwer, L.W. Niessen, M.J. Postma & F.F.H. Rutten (2005). Need for differential discounting of costs and health effects in cost effectiveness analyses. British Medical Journal, 331 (7514), 446-448.
  W.B.F. Brouwer, N.J.A. van Exel & E.A. Stolk (2005). Acceptability of less than perfect health states. Social Science & Medicine, 60, 237-246. doi: 10.1016/j.socscimed.2004.04.032
  R. Klok, W.B.F. Brouwer, L. Annemans, J.M. Bos & M.J. Postma (2005). Towards a healthier discount procedure. Expert review of pharmacoeconomics & outcomes research, 5, 59-63. doi: 10.1586/14737167.5.1.59
  M.A. Koopmanschap, A. Burdorf, K. Jacob, W.J. Meerding, W.B.F. Brouwer & J.L. Severens (2005). Productivity and health in economic evaluation; setting the research agenda. Pharmacogenetics, 23, 47-54.
  L.M. Lamers, W.J. Meerding, J.L. Severens & W.B.F. Brouwer (2005). The relationship between productivity and health-related quality of life: An empirical exploration in persons with low back pain. Quality of Life Research, 14 (3), 805-813. doi: 10.1007/s11136-004-0800-4
  W.B.F. Brouwer & M.A. Koopmanschap (2005). The friction-cost method - Replacement for nothing and leisure for free? Pharmacoeconomics (Print), 23 (2), 105-111. doi: 10.2165/00019053-200523020-00002
  S. Polinder, W.J. Meerding, N.J.A. van Exel & W.B.F. Brouwer (2005). Societal discounting of health effects in cost-effectiveness analyses: the influence of life expectancy. Pharmacoeconomics (Print), 23, 791-802.
  K. Lee, W.B.F. Brouwer, S. Lee & H. Koo (2005). Introducing economic evaluation as a policy tool in Korea: Will decision makers get quality information? A critical review of published Korean economic evaluations. Pharmacoeconomics (Print), 23 (7), 709-721. doi: 10.2165/00019053-200523070-00005
  P. de Wolf, W.B.F. Brouwer & F.F.H. Rutten (2005). Regulating the Dutch pharmaceutical market: improving efficiency or controlling costs? International Journal of Health Planning and Management, 20 (4), 351-374. doi: 10.1002/hpm.819
  F.F.H. Rutten, W.B.F. Brouwer & L.W. Niessen (2005). Practice guidelines based on clinical and economic evidence: indispensable tools in future market-oriented health care. European Journal of Health Economics (HEPAC), 6, 91-93. doi: 10.1007/s10198-005-0278-1
  P. Sendi & W.B.F. Brouwer (2004). Leisure time in economic evaluation: theoretical and practical considerations. Expert review of pharmacoeconomics & outcomes research, 4, 1-3. doi: 10.1586/14737167.4.1.1
  N.J.A. van Exel, B. van den Berg, M.A. Koopmanschap & W.B.F. Brouwer (2004). Mantelzorg: een goed om te waarderen. Nederlands Tijdschrift voor Geneeskunde, 82, 236-242.
  W.B.F. Brouwer, N.J.A. van Exel, B. van den Berg & H.J. Dinant (2004). Burden of caregiving: evidence of objective burden, subjective burden, and quality of life impacts on informal caregivers of patients with rheumatoid arthritis. Arthritis & Rheumatism, 51, 570-577.
  B. van den Berg, W.B.F. Brouwer & M.A. Koopmanschap (2004). Economic valuation of informal care. European Journal of Health Economics (HEPAC), 5, 36-45.
  N.J.A. van Exel, W.J.M. Scholte op Reimer, W.B.F. Brouwer, B. van den Berg, M.A. Koopmanschap & G. van den Bos (2004). Instruments for assessing the burden of informal caregiving for stroke patients in clinical practice: a comparison of CSI, CRA, SCQ and self-rated burden. Clinical Rehabilitation, 18, 203-214. doi: 10.1191/0269215504cr723oa
  F.E. van Nooten & W.B.F. Brouwer (2004). The influence of subjective expectations about length and quality of life on time trade-off answers. Health Economics, 13, 819-823. doi: 10.1002/hec.873
  M.A. Koopmanschap, N.J.A. van Exel, G. van den Bos, B. van den Berg & W.B.F. Brouwer (2004). The desire for support and respite care:preferences of Dutch informal caregivers. Health Policy, 68, 309-320. doi: 10.1016/j.healthpol.2003.10.002
  N.J.A. van Exel & W.B.F. Brouwer (2004). What really matters: an inquiry into the relative importance of dimensions of informal caregiver burden. Clinical Rehabilitation, 18, 683-693. doi: 10.1191/0269215504cr743oa
  W.B.F. Brouwer & N.J.A. van Exel (2004). Discounting in decision making: the consistency argument revisited empirically. Health Policy, 67, 187-194. doi: 10.1016/S0168-8510(03)00115-5
  M.J. Al & W.B.F. Brouwer (2004). Decision makers views on health care objectives and budget constraints; results from a pilot. Health Policy, 70, 33-48. doi: 10.1016/j.healthpol.2004.01.009
  E.A. Stolk, G. van Donselaar, W.B.F. Brouwer & J.J. van Busschbach (2004). Reconciliation of economic concerns and health policy;illustration of an equity adjustment procedure using proportional shortfall. Pharmacoeconomics (Print), 22, 1097-1107. doi: 10.2165/00019053-200422170-00001
  W.B.F. Brouwer & F.F.H. Rutten (2004). Modernisering GVS:een contradictio in terminis? Nederlands Tijdschrift voor Geneeskunde, 82, 463-466.
  W.B.F. Brouwer & F.F.H. Rutten (2003). The missing link: on the line between C and E. Health Economics, 12, 629-636. doi: 10.1002/hec.764
  W.B.F. Brouwer, N.J.A. van Exel, B. Hermans & A.P. Stoop (2003). Should I stay or should I go? Waiting lists and cross-border care in the Netherlands. Health Policy, 63, 289-298. doi: 10.1016/S0168-8510(02)00120-3
  F. Paolucci & W.B.F. Brouwer (2003). Introduzione ad alcuni aspetti di economia sanitaria. Quadernie Associazione Culturale Pediatri, 10, 25-27.
  F.F.H. Rutten & W.B.F. Brouwer (2002). Meer zorg bij beperkt budget; een pleidooi voor een betere inzet van het doelmatigheidscriterium. Nederlands Tijdschrift voor Geneeskunde, 146 (47), 2254-2258.
  E.A. Stolk, W.B.F. Brouwer & J.J. van Busschbach (2002). Rationalising rationing: economic and other considerations in the debate about funding of Viagra. Health Policy, 59, 53-63. doi: 10.1016/S0168-8510(01)00162-2
  W.B.F. Brouwer, N.J.A. van Exel, M.A. Koopmanschap & F.F.H. Rutten (2002). Productivity losses before and after absence: as important as common? Health Policy, 61, 173-187.
  M.J. Poleij, E.A. Stolk, W.B.F. Brouwer & J.J. van Busschbach (2002). Ziektelast als uitwerking van het criterium 'noodzakelijkheid' bij het maken van keuzen in de zorg. Nederlands Tijdschrift voor Geneeskunde, 146 (48), 2312-2315.
  W.B.F. Brouwer & F.F.H. Rutten (2001). Health economics: a bridge over troubled water. European Journal of Public Health, 11, 234-236. doi: 10.1093/eurpub/11.2.234
  F.F.H. Rutten, H. Bleichrodt, W.B.F. Brouwer, M.A. Koopmanschap & F.T. Schut (2001). Book review Handbook of health economics. Journal of Health Economics, 20, 855-879.
  G.T. Koopmans & W.B.F. Brouwer (2001). Comparing patients with depressive complaints and patients with chronic medical conditions on their functioning and medical consumption. Journal of Mental Health Policy and Economics, 4, 91-100.
  W.B.F. Brouwer, B.A. van Hout & F.F.H. Rutten (2000). A fair approach to discounting future effects: taking a societal perspective. Journal of Health Services Research & Policy, 5 (2), 114-118.
  E.K.A. van Doorslaer & W.B.F. Brouwer (2000). Editorial: Waiting lists in the Netherlands: workers first? Journal of Health Services Research & Policy, 5 (3), 129-130.
  W.B.F. Brouwer & M.A. Koopmanschap (2000). On the economic foundations of CEA. Ladies and gentlemen, take your positions! Journal of Health Economics, 19, 439-459.
  W.B.F. Brouwer, B.A. van Hout & F.F.H. Rutten (2000). A fair approach to discounting future effects: taking a societal perspective. Journal of Health Services Research & Policy, 5 (2), 114-114.
  W.B.F. Brouwer, N.J.A. van Exel, M.A. Koopmanschap & F.F.H. Rutten (1999). The valuation of informal care in economic appraisal. International Journal of Technology Assessment in Health Care, 15 (1), 147-160.
  W.B.F. Brouwer & H.E.G.M. Hermans (1999). Private clinics for employees as a Dutch solution for waiting lists: economic and legal arguments. Health Policy, 1-17. doi: 10.1016/S0168-8510(99)00005-6
  W.B.F. Brouwer, M.A. Koopmanschap & F.F.H. Rutten (1999). Productivity losses without absence. Health Policy, 13-27.
  W.B.F. Brouwer & F.T. Schut (1999). Priority care for employees: a blessing in disguise? Health Economics, 65-73.
  W.B.F. Brouwer (1999). Market Limitations in the health care sector. Journal of Health Services Research & Policy, 4 (3), 185-186.
  W.B.F. Brouwer & F.F.H. Rutten (1998). Wachtlijsten en bedrijvenpoli's. Tijdschrift voor Bedrijfs- en Verzekeringsgeneeskunde, 6 (2), 51-54.
  H.E.G.M. Hermans & W.B.F. Brouwer (1998). Bedrijvenpoli's leiden tot tweedeling in de zorg: mythe of realiteit? Nederlands Juristenblad (NJB), 25, 1095-1101.
  J.J. van Busschbach, W.B.F. Brouwer, A. van der Donk & J. Passchier (1998). An outline for a cost-effectiviness analysis of a drug for patients with Alzheimer's disease. Pharmacoeconomics (Print), 13 (1 Pt 1), 21-34.
  J.J. van Busschbach, W.B.F. Brouwer, A. van der Donk & J. Passchier (1998). An Outline for a Cost-Effectiveness Analysis of a Drug for Patients with Alzheimer's Disease. Pharmacoeconomics (Print), 13, 21-34.
  M.A. Koopmanschap & W.B.F. Brouwer (1998). Indirect Costs and Costing Informal Care. Health Economics Approaches to Dementia, 245-256.
  W.B.F. Brouwer & B.A. van Hout (1998). How should different life expectancies be valued? British Medical Journal, 317, 317-317.
  W.B.F. Brouwer, M.A. Koopmanschap & F.F.H. Rutten (1998). Patient and informal caregiver time in cost- effectiveness analysis. International Journal of Technology Assessment in Health Care, 14 (3), 505-513.
  W.B.F. Brouwer, F.T. Schut & F.F.H. Rutten (1997). De opvattingen van Rawls. Economisch-Statistische Berichten, 82 (4094), 153-154.
  W.B.F. Brouwer, M.A. Koopmanschap & F.F.H. Rutten (1997). Productivity costs measurement through quality of life? A response to the recommendation of the Washington Panel. Health Economics, 253-259.
  W.B.F. Brouwer, M.A. Koopmanschap & F.F.H. Rutten (1997). Productivity costs in cost-effectiveness analysis numerator or denominator: a further discussion. Health Economics, 511-514.
  W.B.F. Brouwer & J.J. van Dijk (1996). Salomo en de speltheorie. Economisch-Statistische Berichten, 836-837.
  W.B.F. Brouwer, F.T. Schut & F.F.H. Rutten (1996). Bedrijvenpoli in het licht van Rawls en Pareto. Economisch-Statistische Berichten, 973-975.
  J.J. van Dijk & W.B.F. Brouwer (1996). Salomo en de speltheorie. Economisch-Statistische Berichten, oktober, 2-2.
- W.B.F. Brouwer, F.F.H. Rutten, J.L. Severens, P.H.M. van Baal, T.E.D. van der Grinten, A.H.E. Koolman & N.J.A. van Exel (2011). Economie van de volksgezondheid. Assen: Koninklijke van Gorcum BV
  
  R.E. Leu, F.F.H. Rutten, W.B.F. Brouwer, C. Rutschi & P. Matter (2008). The Swiss and the Dutch health care systems compared. Baden Baden: Nomos
  W.B.F. Brouwer (1999). Time and time costs in economic evaluation: taking a societal perspective. Ridderkerk: Ridderprint
- W.B.F. Brouwer & F.F.H. Rutten (2012). Op naar een effectieve afbakening van het basispakket: kansen en uitdagingen. In Een economische gezonde gezondszorg. Pre-adviezen Koninklijke Vereniging voor de Staatshuishoudkunde 2012 (pp. 67-87). Den Haag: Sdu uitgevers
  N.J.A. van Exel, P.H.M. van Baal & W.B.F. Brouwer (2011). Prikkels voor gezond gedrag: een gezonde zaak? In HW van Lienden & JMD Boot (Eds.), Economie van de volksgezondheid: zorg voor gezondheid=zorg voor welvaart. Assen: van Gorcum
  H. Bleichrodt & W.B.F. Brouwer (2010). Disconteren. In M. Rutten-Van Mölken, F.F.H Rutten & C.A. Uyl-De Groot (Eds.), Van Kosten Tot Effecten Een Handleiding Voor Evaluatiestudies in De Gezondheidszorg (pp. 8-9). Maarssen: Elsevier Gezondheidszorg
  W.B.F. Brouwer & M.A. Koopmanschap (2010). Overige kosten binnen en buiten de gezondheidszorg. In M. Rutten-Van Mölken, F.F.H Rutten & C.A. Uyl-De Groot (Eds.), Van Kosten Tot Effecten Een Handleiding Voor Evaluatiestudies in De Gezondheidszorg (pp. 19-4). Maarssen: Elsevier Gezondheidszorg
  J.J. Polder, P.H.M. van Baal, N.J.A. van Exel & W.B.F. Brouwer (2007). Een economisch verhaal over preventie en de waarde van gezondheid. In Jaarboek Publieke Gezondheid 2007 (pp. 128-3). Abcoude: Stichting Public Health Forum
  F.F.H. Rutten & W.B.F. Brouwer (2007). Economische evaluaties in de gezondheidszorg. In T. Dr Ploch, R.E. Dr Juttmann, N.S. Prof.dr. Klazinga & J.P. Prof.dr Mackenbach (Eds.), Handboek gezondheidszorgonderzoek (pp. 132-10). Bohn Stafleu van Loghhum
  W.B.F. Brouwer & F.F.H. Rutten (2007). Zorgverzekeringen: een centraal gezondheidsonderzoeksgebied. In Handboek gezondheidszorgonderzoek (pp. 208-17). Bohn Stafleu van Loghum
  J. Polder, P.H.M. van Baal, N.J.A. van Exel & W.B.F. Brouwer (2007). Preventie: niet altijd goedkoop, wel vaak een goede koop. Een economisch verhaal over preventie en de waarde van gezondheid. In Jaarboek Publieke Gezondheid (pp. 128-3). Abcoude: Stichting Public Health Forum
  W.B.F. Brouwer, N.J.A. van Exel & E.A. Stolk (2005). Wat heet gezond? De aanvaardbaarheid van ongezondheid op latere leeftijd. In A Wagemakers, J Ubach-Moust & L Christ (Eds.), Tijd van leven, tijd van zorgen: essays over leeftijd, levensloop, gezondheid en zorg. Utrecht: Expertisecentrum Leeftijd
  W. Groot & W.B.F. Brouwer (2003). De volksgezondheid en het volksgezondheidsbeleid. In W. Groot, W.B.F. Brouwer & H. van Lienden (Eds.), Gezondheid een kapitaal goed (pp. 9-16). --: Stichting Public Health Forum
  W.B.F. Brouwer (2003). Disconteren van toekomstig gezondheidskapitaal. In W. Groot, W.B.F. Brouwer & H.W. van Lienden (Eds.), Gezondheid een kapitaal goed (pp. 41-48). --: Stichting Health Forum
  A. de Wit & W.B.F. Brouwer (2003). Gezond gedrag als stiefkindje van economisch evaluatie onderzoek. In W. Groot, W.B.F. Brouwer & H.W. van Lienden (Eds.), Gezondheid een kapitaal goed (pp. 49-58). --: Stichting Public health forum
  W.B.F. Brouwer (2001). Europa, grensoverschrijding en patiëntenmobiliteit. In -- -- (Ed.), Handboek structuur en financiering gezondheidszorg (pp. 1-32). --: --
  W.B.F. Brouwer & M.A. Koopmanschap (2000). Overige kosten binnen en buiten de gezondheidszorg. In M.P.M.H. Rutten- van Mölken, J.J. van Busschbach & F.F.H. Rutten (Eds.), Van kosten tot effecten (pp. 43-62). Maarssen: Elsevier gezondheidszorg
  H. Bleichrodt & W.B.F. Brouwer (2000). Disconteren. In M.P.M.H. Rutten- van Mölken, J.J. van Busschbach & F.F.H. Rutten (Eds.), Van kosten tot effecten (pp. 123-130). Maarssen: Elsevier gezondheidszorg
  
  A.E. Attema & W.B.F. Brouwer (2014). Constant proportional trade-offs and health state evaluations. In AC Michalos (Ed.), Encyclopedia of Quality of Life and Well-Being Research (pp. 1207-1212). Dordrecht: Springer
  W.B.F. Brouwer & F.F.H. Rutten (2012). Health Care Rationing: Balancing Equity and Efficiency. In Health Care Rationing: Hard choices and unavoidable trade-offs (pp. 225-242). Antwerpen: Maklu Publishers
  W.B.F. Brouwer (2010). Perspective, costs, outcome and discounting in pharmacoeconomic evaluations. In F.F.H. Rutten & A.G. Vulto (Eds.), PharmacoEconomics for European hospital pharmacists (pp. 12-1). Mol, Belgie: Pharma Publishing and Media Europe
  W.B.F. Brouwer, N.J.A. van Exel & J.M. Tilford (2009). Incorporating caregiver and family effects in economic evaluation of child health. In W. Ungar (Ed.), Economic Evaluation in Child Health (pp. 55-3). Oxford: Oxford Scholarship Online Monographs
  W.B.F. Brouwer (2009). Welfare, welfarism and extra-welfarism. In M. Kattan (Ed.), Encyclopedia of medical decision making. Thousand Oaks/London/New Delhi/Singapore: Sage Publications
  W.B.F. Brouwer & F.F.H. Rutten (2009). Cost containment and efficency in national health systems; a global comparison. In J. Rapoport, P. Jacobs & E. Jonsson (Eds.), Cost containment and efficency in national health systems; a global comparison (pp. 131-6). Weinheim: Wiley-Blackwell
  W.B.F. Brouwer & F.F.H. Rutten (2008). The Netherlands. In J Rapoport, P Jacobs & E Jonsson (Eds.), Cost Containment and efficiency in National Health Systems. Weinheim: Wiley-Blackwell
  W.B.F. Brouwer, F.F.H. Rutten & M.A. Koopmanschap (2001). Costing in economic evaluations. In M. Drummond & A. McGuire (Eds.), Economic evaluation in health care; merging theory with practice (pp. 68-93). Oxford: Oxford University press
  M.A. Koopmanschap & W.B.F. Brouwer (2001). Controversial costs in guidelines. In -- -- (Ed.), Economic evaluation; from theory to practice (pp. 129-143). --: --
  W.B.F. Brouwer, M.A. Koopmanschap & F.F.H. Rutten (1998). Patient and informal caregiver time in cost-effectiveness analysis. A response to the recommendations of the Washington Panel. In International journal of Technology Assessment in Health Care (14, 3) (pp. 505-513). Cambridge: Cambridge University press
  W.B.F. Brouwer & M.A. Koopmanschap (1997). Kosten binnen en buiten de gezondheidszorg. In D Post & LJ Stokx (Eds.), Volksgezondheid Toekomst Verkenning: zorgbehoefte en zorggebruik (pp. 43-56). Utrecht: ELSEVIER / De Tijdstroom
- W. Groot, W.B.F. Brouwer & H.W. van Lienden (Ed.). (2003). Gezondheid een kapitaal goed. --: Stichting Public health forum
  
  W.B.F. Brouwer, R. Jansen & D. Larmuseau (Ed.). (2004). Health economics adding value to healthcare. --: The Dutch Flemish Health Economic Association Anniversary Bo
- T. Zuiderent, S. Jerak, H.M. van de Bovenkamp, S.S. Tan, L. Hakkaart-van Roijen, W.B.F. Brouwer & R.A. Bal (2011). Variatie in richtlijnen. Wat is het probleem? (Extern rapport). Rotterdam: Instituut Beleid & Management Gezondheidszorg
  T. Zuiderent, S. Jerak, H.M. van de Bovenkamp, S.S. Tan, L. Hakkaart-van Roijen, W.B.F. Brouwer & R.A. Bal (2011). Variatie in richtlijnen. Wat is het probleem? (Intern rapport). Rotterdam: iBMG
  E.A. Stolk & W.B.F. Brouwer (2010). Communicatie en Implementatieplan (CIP) voor het Deelprogramma HTA methodologie onder het hoofdprogramma Doelmatigheidsonderzoek Farmacotherapie. (Intern rapport). Rotterdam: IMTA
  M. Pomp, W.B.F. Brouwer & F.T. Schut (2008). Bekostiging dure geneesmiddelen 2nd opinion NZa-voorstel bekostiging dure intramurale geneesmiddelen. (Intern rapport). onbekend: Health policy and management (BMG)
  W.B.F. Brouwer, A.H.E. Koolman & F.F.H. Rutten (2005). Wat is productiviteitsgroei in de zorg? Een korte, conceptuele beschouwing uit economisch perspectief. (Intern rapport). onbekend: Health policy and management (BMG)
  E.A. Stolk, M.J. Poleij, W.B.F. Brouwer & J.J. van Busschbach (2002). Proeftoetsing van het iMTA model. Identificatie van aandoeningen met minimale ziektelast en proeftoetsing van de voor ziektelast gecorrigeerde doelmatigheidstoets. (Extern rapport). Rotterdam: IMTA
  W.B.F. Brouwer, E.K.A. van Doorslaer & H.E.G.M. Hermans (2000). Juridische en economische aspecten van Europese invloeden op wachtlijsten in de Nederlandse gezondheidszorg. (Extern rapport, ZON-VVS-200005). Den Haag: Zorgonderzoek Nederland
  W.B.F. Brouwer (1999). Het Nederlandse gezondheidszorgstelsel. (Extern rapport). Zoetermeer: Raad voor de Volksgezondheid en Zorg
  W.B.F. Brouwer, S. Ghajar, H.E.G.M. Hermans & A.H.E. Koolman (1999). Grensoverschrijdende zorg in Zeeuws-Vlaanderen Juridische en economische aspecten. (Extern rapport). Erasmus Universiteit Rotterdam: Instituut Beleid en Management Gezondheidszorg
  
  P.H.M. van Baal, N.J.A. van Exel & W.B.F. Brouwer (2015). Kosten van langer leven en de evaluatie van medische technologie. (Extern rapport, Opinion Paper 64). Tilburg: Netspar
  P.H.M. van Baal, P. Obulqasim, W.B.F. Brouwer, W. Nusselder & J. Mackenbach (2013). The influence of health care spending on life expectancy. (Extern rapport). Tilburg: Netspar Panel Papers
- W.B.F. Brouwer, M.A.J.M. Buijsen & F.F.H. Rutten (2003, juni 3). Meer zorg voor minder geld kan nog steeds. Trouw, pp. 1-1.
  W.B.F. Brouwer & F.F.H. Rutten (2003, juli 1). Laat verzekeraars medicijnen inkopen. Trouw, pp. 1-1.
  W.B.F. Brouwer & F.T. Schut (0099, september 10). Per ziekte een maximale wachttijd. Trouw, pp. 0-0.
  W.B.F. Brouwer (1998, januari 12). Voorrang voor velen is vooruitgang voor velen. Trouw, pp. 1-1.
- F.F.H. Rutten & W.B.F. Brouwer (1997). Cost- effectiveness in health and medicine [Bespreking van het boek Cost- effectiveness in health and medicine]. .
- W.B.F. Brouwer (1999, december 3). Time and time costs in economic evaluation: taking a societal perspective. Erasmus Universiteit Rotterdam (171 pag.) (Ridderkerk: Ridderprint) Prom./coprom.: prof.dr. F.F.H. Rutten.
  W.B.F. Brouwer (1999, december 3). Time and time costs in economic evaluation: taking a societal perspective. Erasmus Universiteit Rotterdam (144 pag.) (Ridderkerk: Ridderprint) Prom./coprom.: prof.dr. F.F.H. Rutten.
- W.B.F. Brouwer (2009). De basis van het pakket. Oratie (2009, december 9). Rotterdam: eigen beheer
- V.T. Reckers - Droog (2021, mei 21). Giving Weight to Equity: Improving priority setting in healthcare. EUR Prom./coprom.: prof.dr. W.B.F. Brouwer & prof.dr. N.J.A. van Exel.
  S.A. Lipman (2020, oktober 15). Decisions about Health Behavioral Experiments in Health with Applications to Understand and Improve Health State Valuation. EUR Prom./coprom.: prof.dr. W.B.F. Brouwer & dr. A.E. Attema.
  M.Q.N. Hackert (2020, september 17). Care for well-being: development of the Well-being of Older People measure (WOOP). EUR Prom./coprom.: prof.dr. N.J.A. van Exel & prof.dr. W.B.F. Brouwer.
  S.J. Schawo (2019, december 20). Economic Evaluation of Treatment for Externalizing Disorders in Adolescents -Connecting mental health and economics. EUR Prom./coprom.: prof.dr. W.B.F. Brouwer & dr. L. Hakkaart-van Roijen.
  F.E. van Nooten (2019, maart 21). The person behind the TTO : exploring what influences TTO responses. EUR Prom./coprom.: prof.dr. W.B.F. Brouwer & prof.dr. N.J.A. van Exel.
  W.J.A. van der Deijl (2017, oktober 26). The Measurement of Wellbeing in Economics: Philosophical explorations. EUR (166 pag.) Prom./coprom.: prof.dr. J.J. Vromen, prof.dr. W.B.F. Brouwer & prof.dr. H.R. Commandeur.
  D.R. Rappange (2016, mei 19). Future Health: A Policy and Individual Perspective. EUR Prom./coprom.: prof.dr. W.B.F. Brouwer & prof.dr. N.J.A. van Exel.
  S. Wouters (2016, september 29). Absolutely Relative : on the value of health outcomes. EUR (192 pag.) Prom./coprom.: prof.dr. W.B.F. Brouwer, prof.dr. K.I.M. Rohde & prof.dr. N.J.A. van Exel.
  E.J. van de Wetering (2016, mei 12). Valuing and Refining Outcome Measures for Economic Evaluations in Health Care. EUR Prom./coprom.: prof.dr. W.B.F. Brouwer & prof.dr. N.J.A. van Exel.
  M. Gheorghe (2016, september 15). Quantitative Approaches in Monitoring Population Quality Of Life. EUR Prom./coprom.: prof.dr. W.B.F. Brouwer & dr. P.H.M. van Baal.
  R.J. Hoefman. The impact of caregiving: the measurement and valuation of informal care for use in economic evaluations. EUR Prom./coprom.: prof.dr. W.B.F. Brouwer & prof.dr. N.J.A. van Exel.
  M.M. Versteegh (2014, april 10). Quality of Life in Economic Evaluations of Health. EUR (187 pag.) Prom./coprom.: prof.dr. W.B.F. Brouwer.
  P. Makai (2014, april 10). Moving Beyond The QALY: Economic evaluation in health and scoial care for elderly populations. EUR (195 pag.) Prom./coprom.: prof.dr. W.B.F. Brouwer & prof.dr. A.P. Nieboer.
  L.M. Niëns (2014, januari 10). Affordability in Health Care: Operationalizatoins and applications in different contexts. EUR (192 pag.) (Rotterdam) Prom./coprom.: prof.dr. W.B.F. Brouwer & prof.dr. F.F.H. Rutten.
  A. Bobinac (2012, mei 11). Economic evaluations of health technologies: Insights into the measurement and valuation of benefits. EUR (227 pag.) (Rotterdam: Optima Grafische Communicatie Rotterdam) Prom./coprom.: prof.dr. W.B.F. Brouwer, prof.dr. F.F.H. Rutten & prof.dr. N.J.A. van Exel.
  H.M. Krol (2012, december 21). Productivity costs in economic evaluations. EUR (268 pag.) (Rotterdam: Optima Grafische Communicatie) Prom./coprom.: prof.dr. W.B.F. Brouwer.
  E. Erdogan Ciftci (2012, september 28). Health perceptions and labour force participation of older workers. Erasmus University Rotterdam (172 pag.) (Rotterdam: Tinbergen Institute) Prom./coprom.: prof.dr. E.K.A. van Doorslaer, Prof.Dr. A. Lopez-Nicolas, dr. T.M. Bago d'Uva, prof.dr. O.A. O'Donnell, M. Lindeboom & prof.dr. W.B.F. Brouwer.
PharmacoEconomics
Start date approval
Mar/2019
End date approval
Mar/2022
Place
NZ
Description
Lid Editorial Board
European Journal Health Economics
Start date approval
Nov/2020
End date approval
Nov/2023
Place
NA
Description
Lid Editorial Board
Health Economics
Start date approval
Nov/2020
End date approval
Nov/2023
Place
YORK
Description
Associate Editor
Zorginstituut Nederland
Start date approval
Nov/2020
End date approval
Nov/2023
Place
DIEMEN
Description
Lid Wetenschappelijke AdviesRaad Zinl
BMC journal Cost-effectiveness Res Alloc
Start date approval
Feb/2021
End date approval
Feb/2024
Place
NA
Description
Member Editorial Board
European Journal Health Economics
Start date approval
Feb/2021
End date approval
Feb/2024
Place
NA
Description
Lid Editorial Board
Health Economics
Start date approval
Feb/2021
End date approval
Feb/2024
Place
YORK
Description
Associate Editor
PharmacoEconomics
Start date approval
Feb/2021
End date approval
Feb/2024
Place
NZ
Description
Lid Editorial Board
Stichting TOPGGz
Start date approval
Feb/2021
End date approval
Feb/2024
Place
AMERSFOORT
Description
Voorzitter
Zorginstituut Nederland
Start date approval
Feb/2021
End date approval
Feb/2024
Place
DIEMEN
Description
Lid Wetenschappelijke AdviesRaad Zinl
institute for Medical Technology Assessm
Start date approval
Feb/2021
End date approval
Feb/2024
Place
ROTTERDAM
Description
Member Supervisory Board
Integration project
Title
Integration project
Year
2020
Year level
bachelor 1
Year
2020
Year level
pre-master
Academic Development & Skills
Title
Academic Development & Skills
Year
2020
Year level
bachelor 1
Health Economics
Title
Health Economics
Year
2020
Year level
bachelor 3, bachelor 3, bachelor 3, bachelor 3
Rationing Health Care
Title
Rationing Health Care
Year
2020
Year level
Bachelor 3
Health Economics
Role
Associate Editor
Pharmacoeconomics (Print)
Role
Editorial Board
European Journal of Health Economics (HEPAC)
Role
Editorial Board
Cost Effectiveness and Resource Allocation
Role
Editorial Board
Dean
University
Erasmus University Rotterdam
School
Erasmus School of Health Policy & Management
Country
The Netherlands
Telephone
0104088525
TOPGGz
Additional Information
www.topggz.nl
Role
Independent Chairman
Obtained Wage
no

Address

Visiting address

Burg. Oudlaan 50 3062 PA Rotterdam

Postal address

Postbus 1738 3000 DR Rotterdam

prof.dr. (Werner) WBF Brouwer

More information

Profile

All publications (404)

Article (337)

Professional Publication (65)

Scholarly Publication (272)

Book / Monograph / Book editorial (3)

Professional Publication (1)

Scholarly Publication (2)

Part of book - Chapter (26)

Professional Publication (15)

Scholarly Publication (11)

Book editorship (2)

Professional Publication (1)

Scholarly Publication (1)

Report (11)

Professional Publication (9)

Scholarly Publication (2)

Contribution weekly / daily journal (4)

Book review (1)

Doctoral thesis (2)

Inaugural speech (1)

Supervised Theses (17)

Ancillary activities (11)

PharmacoEconomics

European Journal Health Economics

Health Economics

Zorginstituut Nederland

BMC journal Cost-effectiveness Res Alloc

European Journal Health Economics

Health Economics

PharmacoEconomics

Stichting TOPGGz

Zorginstituut Nederland

institute for Medical Technology Assessm

Teaching (5)

Integration project

Academic Development & Skills

Health Economics

Rationing Health Care

Editorial positions (4)

Health Economics

Pharmacoeconomics (Print)

European Journal of Health Economics (HEPAC)

Cost Effectiveness and Resource Allocation

Present position

Dean

Other positions (1)

TOPGGz

Address

Visiting address

Postal address